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Summary 
 
Glucose is the main energy substrate for the mammalian brain. On a cellular level, however, lactate 
has been discussed as an alternative energy substrate for neurons since the astrocyte neuron lactate 
shuttle (ANLS) was hypothesized more than two decades ago. As brain energy metabolism is known to 
be highly dependent on neuronal activity in vivo, its properties should ideally be investigated in an 
intact organism with a sufficiently high temporal and spatial resolution. Specifically, measurements of 
concentrations and fluxes of the main metabolites glucose, lactate and pyruvate in single cells would 
allow to model the cellular compartmentation of brain energy metabolism. 
 
To follow cellular metabolite levels in the living mouse, the glucose sensors FLIPΔ6, the lactate sensor 
Laconic and the pyruvate sensor Pyronic were expressed using adeno-associated viral vectors and 
recorded with two-photon laser scanning microscopy (TPLSM). In a first part of my MD-PhD project, 
astrocytic and neuronal FLIPΔ6 signals were correlated to increasing blood and extracellular glucose 
levels, identifying the blood brain barrier as a main rate limiting transport obstacle and showing early 
saturation of glucose accumulation in neurons. Sensory stimulation induced only minor and variable 
changes on cellular glucose levels, while electrical intracortical stimulation induced a decrease of 
glucose signals in astrocytes but not in neurons. In the second part of my MD-PhD project, 
simultaneous Laconic measurements in astrocytes and neurons were used. We used intravenous 
pyruvate injections to trans-accelerate the efflux of lactate from brain-cells and found a lactate 
deprivation in astrocytes but not in neurons. Additionally, intravenous ammonium chloride injections 
allowed to increase brain lactate levels in order to saturate Laconic, what occurred at lower signal 
increases in astrocytes than in neurons. Both pronounced trans-acceleration and earlier saturation in 
astrocytes compared to neurons indicate higher baseline lactate levels in astrocytes, as it is expected 
from net-producers of lactate. Cortical microstimulation revealed a fast astrocytic lactate dip, followed 
by a large increase of astrocytic and neuronal lactate levels, which might indicate an active transport 
of lactate towards neurons during increased neuronal activation. The neuronal NH+4 production during 
activation was mimicked by intravenous ammonium chloride that lead to astrocytic and neuronal 
lactate accumulation. 
 
Altogether the combination of metabolic sensors with TPLSM was well suited to follow transients of 
astrocytic and neuronal glucose, lactate and pyruvate signals in the living mouse. More pronounced 
glucose transients and higher lactate levels in astrocytes compared to neurons support the ANLS 
hypothesis.  
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Zusammenfassung 
 
Glukose ist das hauptsächliche Energiesubstrat für das Gehirn von Säugetieren. Auf zellulärer Ebene 
wird jedoch Laktat als alternatives Energie-tragendes Substrat für Neuronen gehandelt, seit vor mehr 
als zwei Jahrzehnten der Astrocyten-Neuronen Laktat Shuttle (ANLS) postuliert wurde. Da bekannt ist, 
dass der Energie-Stoffwechsel des Gehirn stark von der neuronalen Aktivität abhängt, sollte dessen 
Eigenschaften optimalerweise im intakten Organismus untersucht werden und zwar mit einer 
ausreichend hohen zeitlichen und örtlichen Auflösung. Messungen von Konzentrationen und 
Umsatzraten der zentralen Stoffwechselprodukte Glukose, Laktat und Pyruvat in einzelnen Zellen 
würden eine genauere Modellierung der zellulären Kompartimentierung des Energiestoffwechsels des 
Gehirns erlauben. 
Um die zellulären Spiegel von Stoffwechselprodukten in der lebendigen Maus zu untersuchen, wurden 
der Glukose Sensor FLIPΔ6, der Laktat Sensor Laconic und der Pyruvat Sensor Pyronic mit Hilfe von 
adeno-assozierten, viralen Vektoren zell-spezifisch exprimiert und mittels Zweiphotonenmikroskopie 
(TPLSM) aufgenommen. In einem ersten Teil meines MD-PhD-Projektes wurden astrozytäre und 
neuronale FLIPΔ6 Signale mit ansteigenden Glukose Spiegeln im Blut und im Extrazellulärraum 
korreliert, womit die Blut-Hirn-Schranke als hauptsächliches Fluss-limitierendes Transport-Hindernis 
identifiziert und eine frühe Saturierung der Glukose-Akkumulation in Neuronen gezeigt wurde. 
Sensorische Stimulation induzierte nur minimale und variable Änderungen der zellulären 
Glukosespiegel, während elektrische intrakortikale Stimulation ein Absinken der Glukose Signale in 
Astrozyten aber nicht in Neuronen bewirkte.  
In einem zweiten Teil meines MD-PhD-Projektes wurden simultane Laconic-Messungen in Astrozyten 
und Neuronen verwendet. Wir nutzten intravenöse Pyruvat-Injektionen, um den Laktat-Export aus 
Hirnzellen zu trans-accelerieren und fanden einen Laktatentzug in Astrozyten aber nicht in Neuronen. 
Zudem erhöhten wir die Laktat-Spiegel des Gehirns durch intravenöse Ammoniumchlorid-Injektionen 
um damit Laconic zu sättigen, was in Astrozyten bei einem kleineren Signalanstieg stattfand als in 
Neuronen. Zusammengenommen können die verstärkte Trans-acceleration und frühere Saturierung 
in Astrozyten verglichen mit Neuronen mit einem höheren Basis-Laktatspiegel in Astrozyten erklärt 
werden, wie es von einem Netto-Laktatproduzent zu erwarten ist. Experimente mit kortikaler 
Mikrostimulation zeigten eine schnelle astrozytäre Laktat-Senke, welche von einem grossen Anstieg 
von astrozytären und neuronalen Laktatspiegeln gefolgt wurde. Dies könnte auf einen aktiven 
Transport von Laktat in Richtung Neuronen während verstärkter neuronaler Aktivierung hinweisen. 
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Die neuronale NH+4 Produktion wärend Aktivierung wurde durch intravenöse Ammoniumchlorid-
Injektionen imitiert, was ebenfalls zu einer astrozytären und neuronalen Laktat-Akkumulation führte.  
Zusammenfassend kann geschlossen werden, dass die Kombination von metabolischen Sensoren mit 
TPLSM es erlaubte, Transienten von astrozytären und neuronalen Glukose-, Laktat- und Pyruvat-
Konzentrationen in der lebendigen Maus mit zellulärer Auflösung zu messen. Verstärkte Glukose-
Transienten und höhere Laktat-Spiegel in Astrozyten verglichen mit Neuronen unterstützen die ANLS 
Hypothese. 
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Introduction 
 
Brain energy metabolism 
 
Scientific field and its significance 
 
About 10% of the cardiac output, 20% of the whole body oxygen and 25% of the glucose utilization are 
appointed to the brain, although it represents only 2% of the body mass1. This high energetic turnover 
of brain tissue makes our central computational organ extremely vulnerable to failure of glucose and 
oxygen supply: few minutes of oxygen or glucose depletion in the blood compartment induce a loss of 
consciousness. On a cellular level, neurons are the main consumers of energy mostly for membrane 
repolarization and postsynaptic processes involved in signal transmission, which is often located far 
away from the cell body2. Therefore, it is likely that other highly abundant cell types in the ‘glia’ of 
brain might play an essential role in supporting the energetically demanding neurons. The term ‘glia’ 
was coined in 1858 by Rudolf Virchow reflecting the instance that he regarded ‘glia’ as a connective 
substance forming a ‘Nervenkitt’ in which neuronal elements are embedded3. After the identification 
of cellular elements of the neuroglia, the term ‘astrocyte’ was proposed by Michael von Lenhossek 
based on the star-like appearance in the Golgi staining4 and later on categorized into ‘fibrous’ and 
‘protoplasmic’ astrocytes5–7. Consequently, modern neuroscience has identified a variety of possible 
functions of astrocytes such as the controlling of synaptic genesis and functioning, the role as stem 
cells and even influencing cognition5. Concerning neuroenergetics, roles in neurovascular interactions 
and metabolic blood-brain-exchange have been suggested, because of their close morphological 
relationship with neurons and vessels8. However, there is still no consent to the physiological relevance 
of astrocytes in general and to their role for a proper energy supply of the neurons specifically. The 
conservation of astrocytes over many species and their increased densities and volumes in humans in 
comparison to other mammals such as rodents9,10 suggest an important role for brain physiology. 
 
Astrocyte metabolism is altered in a variety of highly prevalent brain pathologies such as Alzheimer’s 
Disease (reactive astrocytes, intracellular Aβ protein accumulation), depression (prefrontal cortex with 
reduced astrocyte density), epilepsy (astrogliosis) or stroke (downregulation of astrocytic glutamate 
transporters and gap junction proteins)11. In the context of this work, the neuropsychiatric syndrome 
called hepatic encephalopathy (HE) is of special interest: An acute or chronic failure of the liver to 
detoxify intestinal ammonia leads to its accumulation in the brain tissue, where it is a substrate of 
astrocytic glutamine synthetase12. Consecutively, brain glutamine, reactive oxygen species (ROS) and 
lactate levels rise inducing brain edema up to a fatal tentorial herniation13. Astrocytes are the only 
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brain cells with a significant energy storage in the form of glycogen, which is neuroprotective during 
acute hypoglycemia, a common and life threatening side effect of insulin therapy of diabetes14. 
 
Localized changes of brain perfusion and metabolism have been used successfully to detect 
physiological and pathological processes non-invasively in the human brain. ‘Functional hyperemia’ 
describes the highly dynamic increase in cerebral blood perfusion accompanying neuronal activation15. 
This neurovascular coupling (NVC) is the theoretical basis to create detailed maps of neuronal activity 
by displaying hemodynamic changes and forms the basis for many heavily used non-invasive 
neuroimaging methods. Functional magnetic resonance imaging (fMRI) takes advantage of the 
differences in the magnetic properties of oxygenated and deoxygenated hemoglobin. This so called 
‘blood oxygenation level-dependent’ contrast measured by fMRI reflects the activity-induced 
spatiotemporal increase of blood volume and blood flow, which exceed the elevated needs of the local 
oxidative metabolism16,17. Another metabolic phenomenon used for functional brain studies is the tight 
association of local glucose consumption with neuronal activity18. For this purpose, positron emission 
tomography (PET) together with 18F-fluorodeoxyglucose (FDG) has been mainly used for the 
measurement of glucose utilization as an important surrogate marker of neuronal activity. 
Additionally, the characteristic changes of FDG-PET signals in pre-symptomatic stages of Alzheimer’s 
Disease might lead to an early diagnostic and progression marker19. The most common diagnostic use 
of FDG-PET is the metabolic characterization of malignant tumors, which prefer aerobic glycolysis over 
oxidative phosphorylation, a phenomenon called after its discoverer Warburg20. This enables anabolic 
metabolism and proliferation also in hypoxic tumor cells and thereby provides the energy substrate 
lactate for hypoglycemic but oxygenated tumor cells, an effect that is especially prominent in the fatal 
astrocyte-derived cancer glioblastoma21.  
 
Astrocyte morphology 
 
The term astrocyte is used for a heterogeneous group of cells in the central nervous system, with the 
main classifications into ‘protoplasmic astrocytes’ in the grey matter, ‘fibrous astrocytes’ in the white 
matter, ‘Bergmann glia’ in cerebellum, ‘Müller glia’ in the retina and ‘radial glia’ during developmental 
neurogenesis22. However, many other less accepted classifications have been suggested based on 
different progenitor cells, differentiation potentials, gene expression patterns, electrophysiological 
properties, interactions with neurons and reactivity in astrogliosis23. Astrocytes close to the dura mater 
and the ventricular endothelium have a distinct morphology with processes covering the brain outer 
surface. In rodents, the processes of protoplasmic astrocytes cover the whole cortex volume with 
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almost non-overlapping territories, while in primates10,24,25. The usage of mouse models to investigate 
astrocyte metabolism imposes limitations to translational validity, as cortical astrocytes in primates 
are several-fold larger, have more small processes and additionally long fibers with varicosities9. 
Cortical neurons are not only organized in distinguishable layers depending on the depth below the 
surface, but they are also topically organized into receptive fields, which has been well characterized 
in the rodents barrel cortex26. Similarly, a pronounced electrochemical coupling of neighboring 
astrocytes within barrels has been observed27.   
 
Astrocytes and neurovascular coupling 
 
Increased neuronal activity is followed by an increase of local blood perfusion, a phenomenon that is 
called ‘neurovascular coupling’ and that is the basis of the BOLD-fMRI signal, which has been widely 
used to functionally map brain regions28.  Astrocytes have large-diameter vascular processes called 
‘endfeet’, which cover most of the vascular surface29, suggesting a role in controlling vascular diameter. 
These endfeet are expressing specific proteins, such as aquaporin 4 channels, Connexin 43 and partially 
glial fibrillary acid proteins (GFAP). Recent in vitro preparations like brain slices and isolated retina 
preparations allowed by using single-cell electrophysiology, microscopy and pharmacological 
manipulations the identification of numerous vasoactive agents implicated in functional hyperemia8. 
Vasodilation and -constriction following neuronal activity could be reproduced by elevating the 
intracellular Ca2+ in astrocytes30,31. Several other mediators, such as metabolites of the cyclooxygenase-
1 (COX) and the cytochrome P450 ω-hydroxylase pathways, lactate, adenosine, adenosine-3-
phosphate, eicosanoids (20-HETE, EET), carbon monoxide, oxygen, H+, NO, astrocytic and smooth 
muscle potassium channels (KCa, Kir) have been identified14,15. 
Between different astrocytes and between processes of the same astrocyte a high density of gap 
junctions has been found32. Connexins (Cx’s) display the molecular constituents of gap junctions. So 
far twenty-one Cx’s have been identified, whereby Cx30 and Cx43 are the main Cx’s in astrocytes. Gap 
junctions allow passage of ions and small molecules up to 1.2 kDa including glucose, lactate, K+, Ca2+ 
and second messengers33. Through these connections astrocytes form functional networks, which 
enable neuroglial and gliovascular interactions, whereas the extent of this coupling is varying between 
different brain regions and different astrocytic subpopulations34. Additionally, astrocytic Ca2+ waves 
have been shown to propagate between perivascular astrocytes via electrical synapses formed by gap 
junctions. Astrocytic networks might also support the delivery of energetic metabolites from blood 
vessels to distal neurons35. However, the main transport limiting barrier for energy substrates are not 
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cellular membranes within the brain tissue but rather the blood brain barrier formed by vascular 
endothelial cells, which chemically isolate the central nervous system from the rest of the body36,37. 
 
Astrocytes and neurometabolic coupling 
 
In this chapter, the potential role of astrocytes in the local increase of brain energy metabolism as it 
can be measured with FDG-PET is discussed.  Beside the above-mentioned endfeet, astrocytes have 
thin processes which cover most of the synapses and dendrites in a distinct area, forming more than a 
million so called ‘tripartite synapses’ each15. Therefore, astrocytic processes are perfectly positioned 
for the removal of glutamate that has been synaptically released by neurons upon neuronal activity. 
After intracellular conversion to glutamine by the enzyme glutamine synthase, which is found 
exclusively in astrocytes38, glutamine is transferred back to neurons. This ‘recycling’ process of 
glutamate is known as the ‘glutamate-glutamine cycle’1,39. Initially, astrocytes were considered to 
support neuronal homeostasis by clearing synaptically released glutamate and potassium and thereby 
sharing the metabolic workload of neuronal signal transmission40. With the so-called ‘astrocyte-neuron 
lactate shuttle’ (ANLS) hypothesis a more active metabolic support for neurons by the astrocytes has 
been suggested: Upon neuronal activity, glutamate is co-transported into astrocytes with Na+, 
activating the Na+/K+-ATPase which stimulates the astrocytic glycolysis to produce lactate, which could 
then be transported into neurons as the preferred energy substrate (for scheme see Figure i-1)41. 
Partial support for the ANLS hypothesis has come from various in vitro and in vivo experiments, which 
are discussed in the section ‘Publication I’ of this thesis and elsewhere42. However, there is still an 
ongoing controversy under what conditions and to what extent such a lactate transfer actually occurs 
in the living mammal43,44. 
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Figure i-1: Concepts of metabolic cooperation between astrocytes and neurons at the tripartite 
synapse. According to the astrocyte-neuron lactate shuttle (ANLS) hypothesis, glucose from the blood 
is preferentially transported into astrocytes using glucose transporters (GLUT). In astrocytes, glucose 
gets metabolized to lactate, which can then be transported towards neurons using monocarboxylate 
transporters (MCT), where lactate can be converted into pyruvate by lactate dehydrogenase (LDH) and 
fuel mitochondrial adenosine triphosphate (ATP) production45. The kinetic properties of GLUT, MCT 
11 
 
and LDH isoforms expressed in the different compartments are discussed in the following sections. 
Neuronal glutamate released into the synaptic cleft is mainly taken up by astrocytes using excitatory 
amino acid transporters (EAATs, human EAAT-2 corresponds to the glutamate transporter 1 (GLT-1) in 
rodents). The coupled Na+ influx into astrocytic activates the Na+/K+-ATPase, which increases astrocytic 
ADP and potassium concentrations and thereby activates astrocytic glycolysis11. Glutamate in 
astrocytes is converted into glutamine using glutamine synthetase, shuttled into neurons and 
converted back to glutamate by neuronal glutaminase to close the glutamate-glutamine cycle45. 
Presynaptically released glutamate can activate ionotropic and metabotropic glutamate receptors at 
the postsynapse, which induce depolarization of neuronal membranes and oxidation of neuronal 
NAD+/NADH-redox states. Excess neuronal NAD+ can be shuttled into astrocytes according to the redox 
switch/redox coupling hypothesis by exchanging neuronal pyruvate for astrocytic lactate using MCTs46. 
Potassium released from activated neurons can be imported and buffered in astrocytic networks by 
gap junctional coupling of connexin (Cx) 30 and 43 expressing astrocytes. Additionally, extracellular 
potassium has been proposed to activate astrocytic lactate export via a lactate channel47. 
 
 
The high glucose uptake of the mammalian brain can be explained by the energy needs for neuronal 
signaling mostly because of the expensive generation of excitatory postsynaptic potentials (EPSP) via 
glutamate receptors48 and the neuronal resting homeostasis49. The most universal intracellular energy 
rich substrate used by neurons is adenosine triphosphate (ATP), which can be converted into 
adenosine diphosphate, monophosphate and other phosphate group donors as energetic coenzymes1. 
The metabolic steps from one glucose molecule to the production of 30 to 36 ATP molecules can be 
clustered into glycolysis, the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, with 
additional branches for glycogenesis and the pentose phosphate pathway (PPP)44. The following 
sections will provide a short overview of the steps, which are most relevant for the understanding of 
the work presented in this thesis. A selection of metabolic pathways involved in ATP production is 
illustrated in Figure i-2. 
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Figure i-2: Selection of pathways involved in cortical generation of the energy rich substrate ATP out 
of glucose. Glycolysis describes the anaerobic degradation of glucose to pyruvate and lactate. 
Glycogenesis allows the storage of glucose in the form of glycogen, which has been found to a limited 
extent in astrocytes but not in neurons50. The pentose phosphate pathway describes an alternative 
metabolic route for glucose, which is important for anaplerosis and the formation of scavengers to 
antagonize oxidative stress. The enzyme pyruvate dehydrogenase links pyruvate to the citric acid cycle 
via acetyl-CoA, which can either enter oxidation via citrate synthase or fill up the tricarboxylic backbone 
via pyruvate carboxylase (in astrocytes but not in neurons51. Alpha-ketoglutarate can be converted to 
glutamate, an important neurotransmitter that astrocytes provide to neurons as glutamine, forming 
the glutamate-glutamine cycle. The reducing agents (such as NADH) produced by glycolysis and the 
citric acid cycle can then be used for the oxidative phosphorylation of ADP to ATP in mitochondria. 
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Glucose uptake 
 
Blood glucose needs to pass the blood brain barrier (BBB) formed by vascular endothelial cells, in order 
to be taken up into the brain tissue. As glucose uptake depends over a large range on its blood 
concentration and diffusion of the hydrophilic glucose molecule over membranes is limited, a low 
affinity transporter must be responsible33.  Glucose transporters (GLUT’s) belong to the solute carrier 
superfamily of membrane transporters, whereby the isoform GLUT-1 (55 kDa) has been localized to 
the vascular endothelium in the brain52. The glucose uptake via GLUT-1 across the BBB has been shown 
to be rate liming in a quantitative model of brain glucose utilization53. GLUT’s are functionally 
symmetrical so that the direction of glucose flux depends solely on substrate concentration gradients 
as described by Michaelis-Menten kinetic equation (see equation E-1, with the transporter and 
substrate specific Michaelis-Menten constant Km, and the maximal rate vmax). The affinities for glucose 
differ between GLUT serotypes: Astrocytes express the low-affinity transporter GLUT-1 (45 kDa, Km of 
5-8 mM) and neurons the high affinity transporter GLUT-3 (Km of 1-2 mM)54,55, which makes neurons 
more efficient glucose importers at low substrate levels but also earlier saturated at higher 
concentrations49. The uniporters can not only transport glucose, but also mannose, galactose and 
dehydroascorbate, which can all contribute to trans-accelerated exchange (for explanation see Figure 
i-3)49.  
      Equation E-1: Michaelis-Menten kinetic model.  
 
Glucose metabolism 
 
The glucose influx into brain tissue depends not only on blood glucose levels but is also highly 
correlated to glucose phosphorylation, indicating a high vmax of the rate limiting enzyme hexokinase50. 
Phosphorylated glucose (glucose-6-P) is not transported across cellular membranes and can either 
enter glycolysis, glycogenesis or the PPP. Glycolysis results in two pyruvate molecules and the 
conversion of two ADP and two NAD+ into ATP and NADH, respectively. The glycogen content of brain 
tissue depends on cellular glucose levels and is relatively low compared to muscles or liver tissue and 
mostly restricted to astrocytes56. The increased glycogen phosphorylase activity (creating glucose-6-P 
and glucose-1-P) and the consecutive lactate buildup during increased neuronal firing led to the 
hypothesis, that astrocytic glycogen might still support neuronal energy needs especially during acute 
rate = v =
d [P]
dt
=
[S]* v
max
K
m
 + [S]
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hypoglycemia50,57. The PPP converts glucose-6-P into ribulose-5-phosphate coupled to the conversion 
of two NADP+ into NADPH, both used for anaplerosis, which is most prominent in the neonatal brain58. 
The second anaplerotic reaction is the conversion of pyruvate into oxaloacetate catalyzed by pyruvate 
carboxylase (PC), which shows substrate competition with the pyruvate analogue oxamate54. PC is 
expressed in astrocytes but not in neurons so that the neurotransmitters glutamate and GABA can only 
be produced in astrocytes before being shuttled into neurons59. Pre-synaptically released glutamate 
can increase astrocytic glucose uptake60 and glycolysis61,62. Synaptic and axonal signaling leads to an 
increase of extracellular potassium, which in turn activates astrocytic glycolysis61. This effect depends 
on the Na+/HCO3- cotransporter NBCe1 via astrocytic membrane depolarization and intracellular 
alkanization63. Astrocytic glycolysis has been shown to be inhibited by the downstream product lactate 
resulting in a negative feedback mechanism64. 
 
Pyruvate and lactate dehydrogenase 
 
In the adult brain glucose is fully oxidized over extended time periods, whereby most ATP (ca. 93%) is 
generated in mitochondria using the TCA cycle and consecutively oxidative phosphorylation 
(OXPHOS)61. Mitochondria are transported along dendrites and axons65 and are therefore found at high 
densities at the pre- and post-synapse66. OXPHOS is linked to glycolysis via the pyruvate dehydrogenase 
(PDH) catalyzed conversion of pyruvate into acetyl coenzyme A, which can then enter the TCA cycle to 
produce succinate and NADH, the reducing substrates for OXPHOS. Indeed, exogenous pyruvate has 
been shown to have the capacity to enter the TCA cycle as an energy substrate for the brain, but it also 
induced seizures67. The epileptogenicity of venous pyruvate could be reproduced in our mouse model 
(data not shown) and has recently been shown to depend on lactate dehydrogenase (LDH) activity68. 
LDH has four subunits (which can be either muscle type M or hearth type H) and catalyzes the 
reversible reaction from pyruvate to lactate coupled to the conversion of NADH to NAD+. This coupling 
leads to a close correlation between the lactate/pyruvate and the NADH/NAD+ ratio69, which makes 
cellular NADH/NAD+ redox states a central regulator of the directionality of intercellular lactate 
fluxes70. Indeed, cytoplasmic and mitochondrial calcium transients are regularly followed by increased 
NAD(P)H autofluorescence71. In hippocampal brain tissue slices, the initial dip of NADH fluorescence 
during electrical stimulation could be collocated with neurons and the delayed overshoot with 
astrocytes72. This finding led to the postulation of the redox switch/redox coupling hypothesis, which 
makes the direction of the lactate shuttle dependent on cytoplasmic redox states and suggests an 
exchange of astrocytic lactate with neuronal pyruvate in order to transfer oxidative equivalents 
produced in active neurons towards astrocytes46.  
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Neurons express the isoform LDH-1, which consists of four H subunits and prefers the reaction towards 
pyruvate due to pyruvate inhibition, while astrocytes also express LDH-5, which consist of four M 
subunits and favors lactate production73. LDH-5 activity increases during alkalization as it happens in 
astrocytes during increased activity74,75, what is further supporting the ANLS hypothesis76.  
 
Lactate transport 
 
Even if glucose is the main energetic compound taken up by human brain tissue, systemic lactate can 
fuel ATP production in the adult brain and is therefore a suitable energy-rich substrate77, even though 
lactate uptake might be only relevant under hyperlactataemic conditions78 such as during physical 
activity79,80. On a cellular level, brain cells are exposed to substantially lower levels of glucose and 
higher levels of lactate than cells in blood plasma81. As already described beforehand, lactate can link 
glycolysis and OXPHOS over different cellular compartments via lactate-shuttles82. Indeed, cultured 
astrocytes export lactate as long as their pH is alkaline83, which is produced from glucose and 
glycogen84. Mitochondrial and cellular lactate shuttles depend on the lactate transport over 
monocarboxylate transporters (MCTs)85. The expression of different MCT serotypes in the main cellular 
compartments of the cortex favors astrocytic export and neuronal import of lactate: Astrocytes 
express the low affinity transporters MCT1 and MCT4, while neurons express the high affinity 
transporter MCT286, notably at the postsynaptic density87. This distribution is similar to lactate 
exporting fast twitch muscle fibers (MCT4) and lactate importing slow twitch muscle fibers (MCT1)88.  
For the present study, we used the trans-acceleration property of MCT, which has previously been well 
characterized in MCT-1 positive erythrocytes (see figure i-3)89. Despite trans-accelerated exchange, 
MCT mediated lactate transport can hardly explain the possibility of lactate flux across astrocytic cell 
membranes against a concentration gradient, which led to the postulation of the existence of a so far 
unknown potassium-dependent lactate channel47.  
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Figure i-3: Scheme of trans-accelerated exchange at Monocarboxylate transporters (MCT). MCTs 
(grey) transport lactate (blue) and pyruvate (pink) across cell membranes, what can be described as 
probabilities of different states of the MCTs (diameter of MCT symbol). Physiological lactate 
concentrations are significantly higher than pyruvate concentrations (left panel). Both substrates 
compete for the same binding site and binding increases the efficiency of translocation of the binding 
site. Each substrate enhances the transport of substrates situated at the opposite side of the 
membrane, a phenomenon called trans-acceleration90. Therefore, an increase of extracellular pyruvate 
enhances the transport of lactate out of the cell (right).   
 
It is still controversial if a lactate shuttle as proposed by the ANSL is relevant at resting conditions or 
only during increased neuronal activity91 or pathological conditions such as brain trauma92. Increased 
neuronal activity leads to a local rise of brain lactate concentrations. Several mechanisms have been 
proposed for the lactate surge, which might act synergistically: AMPA receptors have been shown to 
be involved65, but also the activation of GLUT1 by Na+-glutamate cotransporters60 and the stimulation 
of the Na+-HCO3- cotransporter NBCe163, soluble adenylyl cyclase93 and a lactate channel47 by 
extracellular potassium. NH4+ released by active neurons might additionally prevent astrocytic 
mitochondria from oxidizing pyruvate via mitochondrial acidification94,95. This phenomenon is clinically 
relevant in HE, where intestinal NH4+ induces a LDH-dependent brain lactate rise and consecutive brain 
edema96.  
 
Lactate signaling 
 
Upon neuronal activity, astrocytes release not only lactate, but also second messengers and chemical 
gliotransmitters like glutamate, D-Serine or ATP as part of the ‘tripartite synapse’97. Therefore, L-
lactate might be an additional gliotransmitter, which affects signal transmission in a relatively large 
17 
 
area98. More specifically, lactate was proposed as a volume transmitter that increases neuronal cAMP 
via the lactate receptor GPR81 and affects cellular NADH/NAD+ redox states99. In the brainstem region 
locus coeruleus, astrocytic lactate and exogenous lactate could activate via a not yet identified 
receptor noradrenergic neurons and evoke arousal100. In the ventromedial hypothalamus, counter-
regulatory catecholamine and glucagon secretion has been shown to respond to hypoglycemia101 and 
low lactate levels102. In a hippocampal slice preparation, astrocytic lactate was either constricting or 
dilating arterioles31. Surprisingly, astrocytic lactate release in the hippocampus seems to be essential 
for long-term memory formation103. The physiological relevance of lactate signaling in different brain 
regions will finally depend on the actual lactate concentrations during baseline and neuronal 
activity104. Whether astrocytic lactate is linked to astrocytic calcium transients or the associated 
astrocytic oxygen sensitivity is another unresolved issue105. 
 
Methods 
 
In this method section the basic principles of the methods used in the present work are introduced 
and their limitations are compared with the most relevant alternative approaches available to 
investigate brain energy metabolism. More specific method sections including immunohistochemical 
stainings to control for cell type specific sensor expression and inflammatory response, intrinsic optical 
imaging to map the primary somatosensory cortex106 and extracellular enzymatic lactate and glucose 
electrodes107,108 are provided in the corresponding publication sections. 
 
Two-photon laser scanning microscopy 
 
TPLSM can image several hundred micrometers deep into strongly scattering brain tissue by assigning 
scattered fluorescence to its original coordinates of nonlinear excitation at a defined point in time109. 
The key feature of nonlinear excitation as it has been predicted in the year 1931110 is the relatively low 
absorption cross section (measured in units of Goeppert-Mayer), what allows excitation only with 
sufficiently high photon density, as it can be achieved in the focal point of a converging (pulsed) laser 
beam111. Frame scans of a focal plane can be achieved by laser-scanning with galvo-mirrors and 
temporally coordinated fluorescence detection with photomultiplier-tubes and specialized 
software112.  
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In the present work, data were acquired using a custom-built two-photon laser scanning microscope113 
equipped with a 20x water immersion objective (NA 0.95, Olympus, Japan) and the acquisition 
software Scanimage114. The two fluorescence detection channels (CFP (Brightline HC 475/64 nm) and 
YFP (Brightline HC 542/50 nm); Semrock Inc., Rochester NY, USA) were used. For excitation a tunable 
pulsed laser (MaiTai eHP DS, Spectra-Physics, Santa Clara CA, USA) at 870 nm wavelength was used 
guided through an IR filter HC 770/SP and a dichroic mirror HC BS 506. 
For in vivo imaging of mouse brain surgical preparations are necessary, such as a chronic cranial 
window to increase depth penetration and a head fixation to reduce motion115. Nevertheless, emitted 
light can be absorbed by vascular hemoglobin, the tissue can pulsate due to the breathing or the heart 
beat and fluorophores can be bleached at higher laser powers115. The spatial resolution is limited by 
the point spread function of the microscope, the temporal resolution depends on the pixel dwell time 
and the achievable signal to noise ratio of a measurement depends on the signal amplitude of the 
sensor relatively to the background signal113.  
 
 
Figure i-4: Simplified Jablonski diagram illustrating the energy states of the FRET sensors Laconic and 
Pyronic. Pulsed laser light of 870 nm wavelength is used to induce mTFP fluorescence emission 
(peaking at about 480 nm) and via FRET Venus fluorescence emission (peaking at about 530 nm). Venus 
excitation is also directly induced by the 870 nm laser, as absorption spectra of two-photon excitation 
are broader than for single photon excitation116. The ground and excited electronic states of the donor 
(D0 and D1) and of the acceptor (A0 and A1, respectively) are indicated. h is the Planck constant and c is 
the speed of light.  
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The emitted light can be split into multiple channels of different wavelengths using dichroic mirrors 
and consecutive bandpass filters for simultaneous detection of multiple fluorophores. After bleach-
through correction, this can be used to correlate signals from multiple fluorescent sensors, such as the 
red astrocyte morphology marker SR101 with vascular fluorescein isothiocyanate dextran or the green 
calcium indicator Oregon Green 488 BAPTA-1117. In the present work, sensors were used containing 
two fluorescent domains at the proteins C and the N termini, which can form a donor-acceptor pair 
capable of non-radiative dipole-dipole coupling called ‘Fluorescent Resonance Energy Transfer’ (FRET, 
Figure i-4). The FRET efficiency depends on the orientation and the distance between the two 
fluorophores118. These properties have been used to genetically construct sensors for specific 
substrates with core proteins that are known to change their conformation upon binding of the target 
substrate119. The binding of the substrate either increases or decreases the FRET efficiency and 
therefore affects the ratio of the emitted light from the donor and the acceptor fluorophore 
accordingly (Figure i-5).  These substrate binding kinetics cause the ratio value to correlate with the 
concentration of the substrate ([S]) as described by Michaelis-Menten equation: 
    Equation E-2: FRET sensor kinetics. 
  
The key parameters for calibration of a FRET signal change (ΔFRET) are the maximal amplitude of the 
sensor (ΔFRETmax) and the dissociation constant Kd: 
   Equation E-3: Calibration of FRET sensors. 
 
While the Kd for a given sensor can be characterized in vitro, the ΔFRETmax depends on multiple in vivo 
factors such as optical properties of the microscope, the quality of sensor expression or any signal 
offset such as background signal. It is therefore necessary to calibrate every region of interest (ROI) 
during an experiment to make conclusions about absolute substrate concentrations, ideally with two 
reference points on the in vitro calibration curve. 
 
ΔFRET =
[S]* ΔFRET
max
K
d
 + [S]
 
[S] =
K
d 
*ΔFRET/ΔFRET
max
1 - ΔFRET/ΔFRET
max
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Figure i-5: Illustration of Laconic sensor functionality. An increase in lactate (molecule in blue) 
concentration changes the conformation of the sensor and orientates the yellow fluorescent protein 
(Venus; acceptor) domain away from to the cyan fluorescent protein (mTFP; donor) domain, what 
decreases the FRET efficiency indicated by the increase of the ratio mTFP/Venus. 
 
FRET dyes for metabolism 
 
The use of FRET dyes for intracellular neuronal calcium transients has been used successfully for 
functional measurements of neuronal cell population120,121. FRET dyes specific for energy substrates 
have mainly been used in cell cultures, such as the glucose sensor FLII12Pglu600µ∆6 (FLIP∆6)119. FLIP∆6 
was first characterized in COS-7 cells122 and has been successfully applied in cell cultures123. FLIP∆6 can 
be calibrated in β-escin permeabilized cultured cells to estimate absolute concentrations126. In our 
hands, FLIP∆6 proved to be functional also in the in vivo situation: Under insulin induced hypoglycemia, 
increasing blood glucose within seconds from 0.5 mM to more than 20 mM induced a higher increase 
of FLIP∆6 signal in astrocytes than in neurons (Figure i-6). However, without the possibility to calibrate 
the sensor in vivo, it is not possible to determine whether this difference is due to different baseline 
glucose concentrations or different glucose accumulation in the two cell types. Another principal 
limitation of FRET dye signal interpretation is the fact, that metabolite concentrations rather than 
fluxes are measured. This can be demonstrated with electrical hind-paw stimulation experiments, 
which are known to increase the glucose uptake in the corresponding primary somatosensory cortex: 
FLIP∆6 indicated no changes of neuronal glucose levels and only minor and ambivalent changes of 
astrocytic glucose levels, reflecting the fact that free glucose concentrations are dependent on glucose 
uptake and intracellular glucose phosphorylation (Figure i-6).  
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Figure i-6: Expression and dynamic changes of the glucose sensor FLIP∆6. Under the control of the 
GFAP and synapsin (SYN) promotors, cell-type specific sensor expression for subsequent imaging of 
astrocytic and neuronal FLIP fluorescence, respectively, was possible (A). After 45 minutes of insulin 
infusion, a glucose infusion (B1, single exemplary trial, glucose infusion indicated by grey bar) induced 
an increase in bot cell types.  This increase was higher in astrocytes compared to neurons after 30 
minutes (B2, n = 12 trials, ** p > 0.01). Electrical hindpaw stimulation (400 µA, 4 Hz, 30 sec duration; 
gray bar) led to no overall changes in a population of neurons (C1, mean ± SD) and astrocytes (C2, mean 
± SD). However, a minority of astrocytes showed transients during a 20 seconds hind-paw stimulation 
as shown here in the case of two exemplary neighboring astrocytes with changes in different directions 
- the transients were persistent over five individual imaging session on different days (D2). 
 
In cell cultures and brain slice preparations, the Inhibition-Transport-Method (ITM; Figure i-7) allowed 
measurements of single cell glucose consumption rates (or glycolytic rates) and GLUT transport rates124 
of cultured astrocytes and other cell types125.  This led to the characterization of increased astrocytic 
glycolysis due to increased extracellular potassium and glutamate61,63 and decreased glycolytic rates 
under increased lactate levels64. However, there is no successful application of this method in the intact 
animal so far. 
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Figure i-7: Inhibition-Transport-Method (ITM) for glycolytic rate measurements with FLIP∆6 in a 
cellular compartment. At steady state the intracellular concentration of glucose is kept at a constant 
level and is determined by glucose uptake via glucose transporters (GLUT) and phosphorylation by 
hexokinase (HK). In order to obtain an estimate of flux through HK, a possible strategy is to isolate the 
rate of metabolism by pharmacological elimination of the glucose uptake using the GLUT blocker 
Cytochalasin B. The Vmax of hexokinase can be estimated from the decline in intracellular glucose 
concentration during the blockade of GLUT125. 
 
Another FRET sensor that has been used to investigate brain energy metabolism is the NAD+-NADH 
redox state sensor Peredox, which showed a higher NAD+/NADH ratio in cultured astrocytes compared 
to neurons127. FRET sensors have also been developed for glutamate128 and glutamine129. Recently, a 
FRET sensor specific for lactate called Laconic has been constructed and allowed to follow intracellular 
lactate levels of cultured astrocytes and glioma cells using pyruvate-induced trans-accelerated export 
of lactate and to determine their net lactate consumption or production using the MCT blocker 
phloretin130. More recently, a FRET sensor specific for pyruvate called Pyronic was presented, which 
allowed the quantification of pyruvate transport, production and consumption in cultured HEK293 
cells, astrocytes and neurons131.  
 
The plasmids coding for these sensor constructs can be cloned and loaded into adenoviral vectors for 
expression in target cell types using specific promoters. The astrocyte-specific construct included a 
minimal GFAP promoter (GFaABC1D, sGFAP; kindly provided by Dr. M. Brenner, Department of 
Neurobiology, University of Alabama)132, a beta-globin intron and a poly-adenylation signal. The 
neuronal construct included a human synapsin-1 (SYN) promoter, a Woodchuck Hepatitis Virus post-
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transcriptional regulatory element (WPRE) and a poly-adenylation signal133,134. The two plasmids were 
used to generate AAV serotype 6 (SYN construct) or AAV serotype 9 (GFAP constructs) viral particles 
by co-transfecting the shuttle plasmid with the pDP6 and pDF9 helper plasmids in HEK293-AAV cells 
(Agilent Technologies, Santa Clara, CA). Viral particles were isolated from the cell lysates, using 
iodixanol step gradients and HPLC purification on heparin-binding (AAV6) and ion exchange (AAV9) 
columns.  
 
However, there are major obstacles with in vivo imaging of energy metabolites: First, despite the 
increased depth penetration of TPLSM, an invasive surgical preparation is necessary to access brain 
cortex optically. Second, awake TPLSM imaging has been established in our laboratory121, but the 
necessary head-fixation and training of mice limits the use of pharmacological interventions and 
stimulation intensities. However, anaesthetic agents are known to influence brain energy metabolism; 
especially volatile halogenated anaesthetics such as isoflurane have been shown to significantly 
increase brain lactate levels135,136. But energy metabolite levels can also change with different 
physiological states of the brain, such as extracellular glucose137 and lactate138 levels during different 
sleep stages and wakefulness. Therefore, an appropriate anaesthesia is favorable for a first 
characterization of the sensors FLIP∆6, Laconic and Pyronic in vivo. 
 
To make conclusions about brain energy metabolism using these FRET dyes it is necessary to interfere 
with the steady states of a metabolic pathway with specific, reproducible and fast interventions such 
as electrical stimulation or pharmacological interventions. The compartmentation of neurometabolic 
coupling was investigated with peripheral electrical stimulation (e.g. at the contralateral hindpaw). The 
less physiological direct intracortical microstimulation was used to induce a stronger but still sparse 
neuronal response139. This method allowed to follow intracellular glucose and lactate concentrations 
during locally increased neuronal activity and to observe a reduction of the lactate peak when lactated 
dehydrogenase was blocked pharmacologically (Figure i-8). Other pharmacological interventions used 
in this work included the direct challenge with energy metabolites but also the blockage of transporters 
such as GLUT (Cytochalasin B, phloretin) or MCT (α-cyano-4-hydroxy-cinnamate, AR-C155858). 
Thereby, the BBB is a limiting factor for the convenient peripheral (subcutaneous, intraperitoneal or 
intravenous) administration of drugs. Direct intracortical air-pressure injection of drugs using a 
Picospritzer® is limited to very small injection volumes which are not reproducible enough for 
quantitative measurements which are needed for the ITM. 
 
24 
 
 
Figure i-8: Glucose and lactate concentration transients during intracortical electrical stimulation. A 
pipette was acutely inserted below a chronic cranial window. A stimulation train with currents of -10 
µA or of -50 µA (A1) induced a fast and transient decrease of neuronal ATP, indicating an acute 
disequilibrium of ATP production and consumption (A2). Changes of astrocytic and neuronal glucose 
concentrations upon a stimulation of 50 µA are illustrated for a single experiment (B1) and the whole 
set of experiments (B2; astrocytes: 6 experiments in 3 animals; neurons: 13 experiments in 4 animals). 
The same stimulation induced an increase of astrocytic and neuronal lactate signals in a single 
experiment (C1) and in the whole experimental group (C2). The dip in astrocytic glucose and the 
increase of astrocytic lactate can be explained with a stronger stimulation-induced activation of 
astrocytic hexokinase activity (ΔHKA) than glucose uptake (ΔGLUTA), while neuronal glucose uptake and 
consumption stay balanced (D). According to the ANLS, this lactate increase represents the shuttling 
of astrocytic lactate towards neurons, which is dependent on the conversion between pyruvate and 
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lactate by lactate dehydrogenase (LDH) activity in both cell types. Inhibition of LDH with the substrate 
analogon oxamate (‘oxa’, dark colors, 17 to 24 minutes after 500 mg per kg bodyweight oxamate 
infusion in 3 minutes) reduced the stimulation-induced lactate increase compared to baseline 
conditions (‘base’, bright colors) in an exemplary single experiment (E1) and in the whole set of 
experiments (E2 left, * p < 0.05 in paired t-test). In both conditions neuronal Laconic amplitudes were 
higher in neurons compared to astrocytes (E2 right).  
 
 
Aims of the current project 
 
The established methods to investigate brain energy metabolism such as enzymatic quantifications, 
MRS or radiotracer methods have led to the postulation of a cellular compartmentation between 
neurons and astrocytes such as the ANLS hypothesis. However, the evidence for the controversial ANLS 
hypothesis is based on methods with key limitations: Measurements are invasive (post mortem 
concentrations140, autoradiography141), lack of cellular resolution (microdilalysis142,143, MRS144, FDG-
PET145,146), are in silico (modeling2,147), are in vitro (cell cultures, modeling), are indirect 
(immunohistochemistry) or require artificial labeling (6NBDG143–145, 2NBDG145,146 or IR2DG41). 
More direct in vivo evidence for a cellular compartmentation of brain energy metabolism requires a 
method that combines cellular specificity, a sufficient spatial resolution, sub-second temporal 
resolution and a high enough signal to noise ratio that allow the detection of localized low-amplitude 
metabolite transients. TPLSM in combination with genetically encoded metabolite sensors in living 
mice holds the potential to fulfill these requirements, if the method can be optimized to achieve a 
signal quality sufficient to capture physiological transients. The complex nature of this new method 
makes it necessary to optimize TPLSM in mouse cortex for metabolic imaging while keeping the mouse 
in a physiological state: Interventions are needed to calibrate metabolic sensors for concentration 
measurements and to read out key metabolic rates in order to make statements about competing 
hypothesis of brain energy metabolism. 
 
I) The first aim of this project was the implementation of the methodology to use TPLSM in 
combination with metabolite sensors for glucose, lactate and pyruvate in the intact brain. 
 
II) The second aim was to compare the astrocytic with the neuronal glucose transport capacities, 
consumption rates and activity dependent transients: Therefore, the cellular accumulation of glucose 
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during increased supply, the glucose consumption rates using ITM and transients under increased 
neuronal activation were investigated, respectively.  
 
III) The third aim was to calibrate the lactate sensor Laconic in vivo in order to compare astrocytic with 
neuronal lactate levels. Based on this calibration, lactate accumulation during increased blood lactate 
levels, neuronal activation (electrical somatosensory stimulation and direct intracortical stimulation) 
and metabolic conditions (ammonium chloride, anaesthesia) were investigated. 
 
IV) The final aim of this project was to use the acquired data to draw conclusions regarding the ongoing 
debate over the cellular compartmentation of brain energy metabolism. Qualitative and quantitative 
models are needed to either support existing hypothesis or adjust them. 
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Summary 
The determination of lactate dynamics in brain tissue represents a challenge, partly because in vivo 
data at cellular resolution are not available. Here we monitored lactate in astrocytes and neurons of 
the primary somatosensory cortex of mice using the genetically-encoded FRET sensor Laconic in 
combination with two-photon laser scanning microscopy. An intravenous lactate injection rapidly 
increased the Laconic signal in both astrocytes and neurons, demonstrating high lactate permeability 
across the tissue. The signal increase was significantly smaller in astrocytes pointing to higher basal 
lactate levels in these cells, confirmed by a one-point in vivo calibration protocol.  
Trans-acceleration of the monocarboxylate transporter with pyruvate was able to reduce intracellular 
lactate in astrocytes but not in neurons. Collectively, this data provides in vivo evidence for a lactate 
gradient from astrocytes to neurons.  
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Introduction 
The energy demand of mammalian brain tissue is met mainly by degradation of blood borne glucose. 
Classical experiments with radiolabeled substrates showed label incorporation into glutamate and 
glutamine in a manner suggestive of two separate tricarboxylic acid cycles, a ‘large’ and a ‘small’ 
compartment (Van den Berg et al., 1969), which were assigned to neurons and astrocytes respectively 
using immunohistochemical techniques (Martinez-Hernandez et al., 1977). The concept of 
compartmentation in brain energy metabolism gained new momentum with the postulation of the 
astrocyte neuron lactate shuttle model (ANLS). In the classical version of this hypothesis, glutamate 
transients are linked to a cellular compartmentation of lactate (Pellerin and Magistretti, 1994). 
Glutamate released from active neurons activates astrocytic glycolysis leading to production of lactate, 
which serves as an energy source for neurons. Increased brain lactate levels upon neuronal activation 
have been observed in several studies via different techniques (Hu and Wilson, 1997; Lin et al., 2010; 
Prichard et al., 1991; Sappey-Marinier et al., 1992). Also, L-lactate acts as a signaling molecule in certain 
mammalian brain regions (Mosienko et al., 2015; Tang et al., 2014; Yang et al., 2014). However, the 
cellular origin of lactate released during increased activity (Barros and Deitmer, 2010; Stobart and 
Anderson, 2013) and its significance as an energy substrate or signaling molecule remains largely 
unclear (Barros, 2013; Weber and Barros, 2015).  
Experimental evidence from in vitro and in vivo animal studies demonstrate that lactate is able to 
sustain neuronal activity during glucose deprivation (Schurr, 2002; Wyss et al., 2011) and patients with 
non-penetrating traumatic brain injuries use peripheral lactate as brain energy substrates (for review 
see Glenn et al., 2015). Furthermore, lactate transport across cell membranes via monocarboxylate 
transporters (MCTs) is a facilitated transport (Halestrap and Wilson, 2012). Increased lactate 
production in one cell type and predominant lactate consumption in another cell type would therefore 
require a lactate concentration gradient from the ‘producer’ to the ‘consumer’. Lactate dehydrogenase 
(LDH), located in mitochondria and the surrounding cytoplasm (Brooks et al., 1999), links lactate to 
oxidative metabolism, by catalyzing the conversion between lactate and pyruvate.  The higher affinity 
for lactate of MCT and LDH isoforms expressed in neurons (MCT2 and LDH1) relative to the isoforms 
expressed in astrocytes (MCT1/4 and LDH5) supports an astrocytic production and neuronal 
consumption of lactate (Bittar et al., 1996; Debernardi et al., 2003; Laughton et al., 2000; Pierre and 
Pellerin, 2005). Inhibition of astrocytic production and neuronal consumption of lactate via LDH 
inhibition reduces epileptic neuronal activity, possibly due to neuronal ATP depletion (Sada et al., 
2015). Moreover, the fast and transient lactate depletion in astrocytes during different in vivo and in 
vitro stimulation paradigms may represent the emptying of a lactate pool (Sotelo-Hitschfeld et al., 
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2015). Taken together, these results suggest a lactate concentration gradient from astrocytes to 
neurons; however, in vivo evidence of such a cellular gradient is currently absent.  
Here, we investigated cell-specific lactate reservoirs in vivo employing the recently developed 
genetically encoded biosensor Laconic (San Martín et al., 2013), which we specifically expressed in 
astrocytes and neurons. Through two-photon laser scanning microscopy (2PLSM; Denk et al., 1990), 
we show, for the first time, direct indication of an in vivo lactate gradient from astrocytes to neurons. 
 
Results 
Expression of Laconic and Pyronic in vivo 
To evaluate the specificity of Laconic transients, a biosensor construct specific for pyruvate (‘Pyronic’; 
San Martín et al., 2014) was measured simultaneously with Laconic. Different adeno-associated viral 
(AAV) vectors, encoding either the Laconic or the Pyronic sensors, were injected in close distance to 
each other at the center of a craniotomy in the primary somatosensory cortex of mice (Figure 1A, S1A). 
The fluorescence of both sensors, driven by the short GFAP promoter, was located in the cytoplasm 
and showed the typical morphology of protoplasmic cortical astrocytes, including vascular end-feet 
and fine processes outlining dark non-fluorescent cells (Figure 1B). A similar fluorescence pattern was 
found throughout all imaged cortical layers, consistent with non-overlapping astrocytic domains in 
mice (Oberheim et al., 2009). Human synapsin promoter constructs induced cytoplasmic fluorescence 
in cells matching neuronal morphology, with dark nuclei and long ranging processes toward superficial 
or deeper structures, located more than 150 µm below the dura (Figure 1B). 2PLSM was restricted to 
layer 2/3 cells with a laser power above 20 mW to ensure stable FRET ratios (Figure S1F) and below 40 
mW to prevent tissue damage and bleaching of the fluorescence. Immunohistochemical staining for 
GFAP, CD68 and fibrinogen revealed no increase in gliosis, microglial activity or blood-brain barrier 
leakage (Figures S1A-D).  
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Figure 1. Expression of Laconic and Pyronic in vivo. (A top) 3D-Structure of the lactate sensor Laconic, 
which was excited with a pulsed laser (870 nm). Emission was collected for mTFP (450-475 nm) and for 
Venus (535-550 nm). (A bottom) The fluorescence (480 nm excitation, 505-565 nm emission, green) of 
four individual sensors was collected through a chronic cranial window preparation of the primary 
somatosensory cortex of a C57BL/6 mice, scale bar: 1 mm. (B top) Serotype 6 adeno-associated viral 
vector (AAV6) with a synapsin promoter was used for neuronal expression, and serotype 9 vector 
(AAV9) with a sGFAP promoter for astrocytic expression. (B bottom) 2PLSM at 150 to 250 µm below 
the dura shows cell-type specific cytoplasmic sensor expression with nuclear exclusion (arrow heads), 
vascular end feet (arrows) and cellular processes (stars); scale bars: 50 µm. (C) The in vitro calibration 
curve of Laconic at 37°C shows substrate binding kinetics of lactate but no pH sensitivity. See also 
Figure S1A to E. 
 
Laconic sensor functions are comparable in vivo and in vitro 
L-lactate binding induces a conformational change of Laconic causing a decrease in fluorescent 
resonance energy transfer (FRET) efficiency which increases the ratio of mTFP (monomeric teal 
fluorescent protein) over Venus (Figure 1A). In vitro lactate application leads to two-site saturable 
Laconic kinetics without pH sensitivity (Figure 1C and S1F, San Martín et al., 2013). The functionality of 
the sensor in vivo was demonstrated with increasing doses of sodium-L-lactate injected via a tail vein 
catheter during 2PLSM. Laconic signals in neurons and astrocytes increased non-linearly with the 
intravenously injected lactate dose but did not respond to 500 mM saline injections (Figure 2A, S1E). 
The amplitudes of Laconic signal changes in vivo were of the same order of magnitude as in vitro cell 
culture, where Laconic signals can be explored at a much wider range of lactate concentrations (Figure 
2B). 
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Figure 2. Laconic sensor functions in vivo. (A) Laconic signals increased both in astrocytes and neurons 
depending on the intravenously injected lactate dosage (Lac; 500 mM L-lactate solution; 0.5, 1 and 2 
mmol per kg bodyweight; 0 mmol lactate was performed with 2 mmol per kg bodyweight of 500 mM 
sodium chloride solution). The standard deviations of cells in a single experiment (left) and of multiple 
independent experiments (right) are indicated (from 0 to 2 mmol/kg; normalization to individual 
baseline). See also Figure S1F, S1G, S3A and S3B. (B) Similarly, Laconic expressed in cultured astrocytes 
and neurons showed dose dependent signal increases. Data are normalized to pyruvate induced 
lactate depletion (see Figure S2D and S2E). Astrocytes but not neurons maintain sizable intracellular 
lactate levels even in a zero glucose and lactate medium, resulting in relatively low Laconic signal 
increases. 
 
A single intravenous injection of lactate increases Laconic signal more in neurons than in 
astrocytes 
To compare lactate accumulation in astrocytes and neurons, Laconic was simultaneously measured in 
neurons and astrocytes during short intravenous L-lactate infusions over three minutes (4 mmol/kg 
bodyweight), elevating blood lactate levels from 0.81 ± 0.26 mM to 17 ± 5.7 mM (Figure 3C). The 
Laconic signal increased more significantly in neurons than in astrocytes (5.7 ± 1.3% vs. 4.3 ± 1.3%, 
respectively; Figure 3A) with a rise in extracellular lactate levels of 0.27 ± 0.08 mM (Figure 3B). This 
discrepancy between neurons and astrocytes could reflect higher lactate accumulation in neurons at 
similar baseline lactate concentrations in both cell types. Alternatively, this difference could be 
attributed to lower baseline lactate concentrations in neurons, which would permit a greater upward 
dynamic range and sensitivity of Laconic. 
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Figure 3. An intravenous injection of lactate increases Laconic signals more in neurons than in 
astrocytes. (A) Intravenous lactate infusions (4 mmol per kg bodyweight in 3 minutes, 500 mM 
solution) increased neuronal (5.7 ± 1.3%) more than astrocytic Laconic signal (4.3 ± 1.3%) in 
simultaneous recordings in one experiment (left) and over multiple recordings (right, normalization to 
individual baseline, mean on peak amplitudes, * = p < 0.05). See also Figure S3C. (B) The same lactate 
infusion protocol increased extracellular lactate (N = 6 animals, 0.27 ± 0.08 mM). (C) Blood lactate 
concentrations rose from 0.81 ± 0.26 mM to 17 ± 5.7 mM (N = 7 experiments). Data are represented 
as mean ± SD. 
 
To distinguish between these two possibilities, the baseline lactate concentrations in astrocytes and 
neurons were compared by saturating Laconic in both cellular compartments. Ammonium chloride 
infusion over four minutes (2.5 mmol/kg bodyweight), which boosts cytosolic lactate concentration in 
brain cells by inhibiting mitochondrial pyruvate consumption (Lerchundi et al., 2015), increased 
Laconic signals in neurons and astrocytes (7.3 ± 1.3% vs. 7.4 ± 1.6%, respectively; Figure S1H). When 
ammonium chloride and L-lactate were simultaneously infused intravenously beforehand, additional 
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L-lactate application induced a significantly smaller increase of the Laconic signal in neurons (0.95 ± 
0.62%, n = 53,  p < 0.05, one-sample t-test) and astrocytes (0.57 ± 0.55%, n = 43 cells, p < 0.05, one-
sample t-test) (Figure 4A) compared to the same lactate infusion in Figure 3 (p < 10-7, two-sample t-
test). However, extracellular lactate levels continued to increase with additional lactate infusion by 16 
± 10.7% of the total increase (p < 0.05, one-sample t-test) (Figure 4B). This suggests that ammonium 
chloride administration increased intracellular lactate concentrations to levels which saturated 
Laconic. Overall, a greater change in neuronal Laconic signal was observed (∆FRET signal: 9.9 ± 2.4 %) 
compared to astrocytes (6.9 ± 2.0 %), supporting our hypothesis of lower baseline lactate levels in 
neurons (Figure 4A).  
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Figure 4. Baseline lactate levels in astrocytes and neurons can be compared by saturating Laconic. 
(A) Astrocytic and neuronal Laconic and Pyronic were simultaneously recorded during an intravenous 
infusion of ammonium chloride (4 mmol per kg bodyweight in 15 minutes, 500 mM solution) mixed 
with lactate (8 mmol per kg bodyweight in 15 minutes, 1 M solution), followed by a faster lactate 
injection (4 mmol per kg bodyweight in 3 minutes, 500 mM solution). Pyronic signals decreased during 
the ammonium chloride-lactate mix. In eight independent experiments, normalization to the 
saturation level of Laconic revealed lower baseline levels in neurons than in astrocytes (0.901 ± 0.024 
vs. 0.931 ± 0.020, normalization to the three minutes after ammonium chloride stop, mean of baseline 
minima, * = p < 0.05). (B) Using the same infusion protocol, changes in extracellular lactate 
concentrations were measured in five trials. Extracellular lactate increased until the end of the infusion 
protocol by 0.87 ± 0.29 mM. Data are represented as mean ± SD. See also Figure S1H and S1I. 
 
36 
 
Pronounced trans-acceleration in astrocytes occurs at baseline 
Pyruvate application has been used in vitro to decrease intracellular lactate levels in erythrocytes 
(Fishbein et al., 1988). This effect is based on a property of MCTs called trans-acceleration (Figure 5E), 
where the presence of extracellular monocarboxylates stimulates transporter substrate efflux. This 
process involves a facilitated conformational switch of the substrate binding site across the cell 
membrane when an adequate substrate is bound (Figure S2G, Garcia et al., 1994; Halestrap, 2013).  
To test the capacity of intravenously applied pyruvate to produce a trans-acceleration-induced lactate 
efflux out of brain cells, extracellular brain lactate levels were measured with Pinnacle© biosensors 
(Figure S3D). Intravenous injection of 4 mmol/kg pyruvate over three minutes induced a transient 
increase of extracellular lactate levels of 0.084 ± 0.022 mM (Figure 5B), consistent with trans-
acceleration of MCTs.  
To compare trans-acceleration of MCTs in neurons and astrocytes, simultaneous measurements of 
Laconic and Pyronic during pyruvate application were performed. At baseline lactate levels, pyruvate 
decreased Laconic signal in astrocytes (-4.7 ± 1.5%), while signal in neurons was relatively unchanged 
(-0.6 ± 0.9%; Figure 5A). Pyronic showed only minor changes. However, after achieving higher 
intracellular lactate concentrations by the combined infusion of ammonium chloride and lactate, 
pyruvate administration was able to decrease Laconic signals in both astrocytes and neurons while 
increasing Pyronic signals in both cells (Figure 5C). Upon repeated i.v. injections of pyruvate, neuronal 
Laconic signal kept increasing, possibly due to the conversion of pyruvate to lactate (Gonzalez et al., 
2005). Under these high lactate conditions, both astrocytes and neurons show trans-acceleration 
(Figure 5D), demonstrating that neuronal MCTs are also susceptible to pyruvate-driven efflux (Figure 
5E). In a subset of recordings this lactate accumulation was absent in neurons, in which case a lactate 
depletion during pyruvate infusions could not be observed. 
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Figure 5. An intravenous injection of pyruvate decreases Laconic signals more in astrocytes than in 
neurons. (A) Intravenous pyruvate infusions (4 mmol per kg bodyweight in 3 minutes, 500 mM 
solution) decreased Laconic signal in astrocytes more than in neurons, while inducing only minor 
changes in Pyronic signal, as observed during simultaneous recordings in one experiment (left, 
normalization to individual baseline). Similar effects were observed over multiple recordings (right, 
normalization to individual baseline, maximum decrease of astrocytes was 4.7 ± 1.5 and of neurons 
0.6 ± 0.9 %, * = p < 0.05). (B) The same pyruvate infusion protocol increased extracellular lactate (N = 
6 animals, 0.084 ± 0.02 mM). (C) The Laconic saturation protocol (see figure 4) was followed by a 
pyruvate infusion, which induced a decrease of astrocytic and neuronal Laconic signal and an increase 
in Pyronic signal. Normalization to three minutes after cessation of ammonium chloride infusion. (D) 
In some trials repetitive pyruvate infusions increased Laconic signal in neurons, possibly due to 
conversion of pyruvate to lactate. With this artificially increased neuronal lactate levels, a pyruvate 
infusion (2 mmol per kg bodyweight in 1 minute, 500 mM solution) induced trans-acceleration also in 
neurons. Normalization to last minute of trace. (E) Trans-acceleration occurs at monocarboxylate 
transporters (MCT), because the substrate binding site of MCTs switches at a higher rate to the other 
side of the membrane when a substrate is bound (MCT – S; k2) than without a substrate bound (MCT; 
k1). Therefore, any substrate of MCT on one side of the membrane increases the rate of transport of 
another substrate in the opposite direction. Data are represented as mean ± SD. See also Figure S2. 
 
Discussion 
The compartmentation of brain energy metabolism is a subject of intense debate, fuelled by a lack of 
accurate in vivo intracellular lactate measurements in different cell populations. Here, we utilized the 
genetically encoded lactate sensor Laconic to observe the capacity of blood borne lactate to enter both 
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astrocytes and neurons and to approximate lactate concentrations in these cells. Whole brain tissue 
uptake of lactate from blood has previously been demonstrated in vivo (Cremer et al., 1979; Klein and 
Olsen, 1947; Wyss et al., 2011) and has been quantified in humans (Glenn et al., 2015; van Hall et al., 
2009). We observed an accumulation of cellular and extracellular brain lactate during artificially 
increased blood lactate levels, which indicate a net uptake under these conditions and is in agreement 
with findings in humans (Boumezbeur et al., 2010; Quistorff et al., 2008; Rasmussen et al., 2011). The 
ability of neurons to take up lactate is an important prerequisite for the use of lactate as an energy 
substrate as suggested by the ANLS (Bélanger et al., 2011; Magistretti and Allaman, 2015), a concept 
that is still debated (Dienel, 2012 and references therein). Lactate has been shown to enter oxidative 
energy production in physiological resting conditions (Bouzier-Sore et al., 2006) and support neuronal 
activity under low-glucose conditions both in vitro (Tekkök et al., 2005) and in vivo (Herzog et al., 2013; 
Wyss et al., 2011). 
We observed a greater neocortical Laconic signal increase in neurons than in astrocytes when blood 
lactate was elevated. This cell type difference was not due to altered Laconic sensitivity, as cumulative 
signal amplitudes were similar in both populations after decreasing intracellular lactate with pyruvate 
infusions and normalizing to the saturated sensor (Figure S1I). Therefore, baseline neuronal lactate 
levels could be lower where Laconic is more responsive. To evaluate this possibility, Laconic was 
saturated in both cellular compartments simultaneously using a mixture of lactate and ammonium 
(Provent et al., 2007), which revealed a higher maximal increase of neuronal Laconic and suggests a 
lower baseline lactate concentration in neurons than in astrocytes (Figure 6A). 
We utilized the trans-acceleration property of MCTs (Brown and Brooks, 1994) by applying an inward 
pyruvate gradient to force the cells to release their lactate. The pronounced drop of astrocytic lactate 
and the negligible decrease in neurons is in agreement with higher resting lactate levels in astrocytes 
(Figure 6B). We can reject the following alternative explanations for the astrocyte-specific lactate drop: 
First, cell-type specific expression of isoforms in the brain has been reported with MCT1 mainly 
expressed in astrocytes and oligodendrocytes and MCT2 in neurons (Pellerin et al., 2005). We assessed 
the influence of MCT isoforms on trans-acceleration with a numerical model and demonstrated an 
almost linear dependency of the pyruvate-induced trans-acceleration on intracellular baseline lactate 
levels for both MCT1 and MCT2 (Figure S2A-C). However, the relatively higher affinity of MCT2 than 
MCT1 for pyruvate in our model would predict stronger trans-acceleration of MCT2, i.e. in neurons 
(Figure S2A-C). Also, trans-acceleration can be induced in cultured neurons (Figure S2E) and astrocytes 
(Figure S2F), where baseline lactate levels depend on the experimental conditions. The differential 
MCT isoform expression and kinetics can therefore not explain the predominant trans-acceleration in 
astrocytes.  
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Second, LDH diminishes lactate depletion caused by pyruvate uptake over time by transforming 
pyruvate into lactate. Intracellular lactate levels start to increase during pyruvate exposure if the rate 
of LDH-catalyzed conversion of pyruvate to lactate is high compared to lactate transport (Figure S2C) 
which may explain the delayed increase in lactate we observed following pyruvate infusion (Figure 5A). 
However, the lower NADH/NAD+ ratio in neurons compared to astrocytes (Hung et al., 2011) implies 
weaker conversion of pyruvate to lactate and is therefore unlikely to mask pyruvate induced lactate 
depletion in neurons. 
Third, the brain vasculature is almost entirely covered by astrocytic endfeet (Mathiisen et al., 2010; 
McCaslin et al., 2011). Therefore, astrocytes are predominantly exposed to blood-borne pyruvate. The 
main transport limiting barrier for blood-borne pyruvate to enter brain tissue is MCT1 at the 
endothelial membranes and the fast diffusion within the tissue will expose all brain cells similarly 
(Halestrap, 2013; Miller and Oldendorf, 1986). Accordingly, we did not observe any temporal 
differences between astrocytic and neuronal lactate accumulation (Figure 2A and 3A). Additionally, 
buffering of lactate by Laconic is unlikely, because baseline lactate levels are higher (hundreds of µM 
instead of nM) and lactate transients are slower (multiple seconds instead of ms) than in the case of 
calcium dynamics, where buffering by the sensor is reported to be an issue (Grienberger and Konnerth, 
2012). Finally, increasing lactate levels in neurons lead to trans-acceleration and lactate efflux in 
neurons similarly as in astrocytes (Figure 5C-D).  
A higher resting state lactate level in astrocytes in comparison to neurons has significant implications 
for transcellular lactate exchange. Intracellular lactate accumulation driven by increased blood lactate 
and depletion during increased blood pyruvate is consistent with a facilitated transport of lactate via 
MCTs. The direction of a facilitated transport is determined by the concentration gradient, for which 
we found evidence to be from astrocytes to neurons as has been suggested by the ANLS (Pellerin and 
Magistretti, 1994) (Figure 6A). However, alternative lactate transport mechanisms have been 
suggested, such as via pannexins and connexins (Barros, 2013; Giaume et al., 2013) or an unknown 
potassium-dependent ion channel, which would allow active lactate transport even against a chemical 
concentration gradient during increased neuronal activity (Sotelo-Hitschfeld et al., 2015). 
In addition, astrocytic lactate could provide a small but fast energy reserve; cultured astrocytes have 
been shown to preferentially export glucose-derived lactate rather than lactate derived from glycogen 
(Sickmann et al., 2005). Glycogen may serve as a slower energy pool, as astrocytic glycogen-derived 
lactate sustains neuronal function in rat optical nerve preparations for several minutes (Brown and 
Ransom, 2007). 
Our data provide important information about lactate concentrations of the different cellular 
compartments, which are fundamental for the role of lactate as an activity dependent signaling 
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molecule (Mosienko et al., 2015). The transport of lactate from astrocytes to neurons has been shown 
to be necessary for the establishment of long-term memory (Suzuki et al., 2011) by inducing the 
expression of plasticity-related genes (Yang et al., 2014). Volatile halogenated anesthetics such as 
isoflurane are known to increase brain lactate levels (Boretius et al., 2013; Horn and Klein, 2010) and 
Fünfschilling and colleagues (Fünfschilling et al., 2012) reported a marked decrease in tissue lactate 
concentration in response to the discontinuation of isoflurane anesthesia, indicative of a substantial 
lactate exchange. In our study, we used injectable anesthetics to avoid elevated lactate levels, but our 
results can be used to interpret the direction of isoflurane-induced lactate exchange at the cellular 
level. It is important to note, however, that Laconic did not enable us to measure cellular or whole 
brain lactate transport or oxidation rates in vivo, as currently available pharmacological agents (such 
as the MCT blocker α-cyano-4-hydroxycinnamate) are neither fast (seconds) nor specific (limited side 
effects) enough.   
 
 
Figure 6. Model of lactate compartmentation. (A) Astrocytes accumulate lactate, which is transported 
along a concentration gradient via monocarboxylate transporters (MCT) to be consumed by neurons. 
Physiological (phys.) and experimentally increased (exp.) blood lactate levels are indicated. (B) Under 
artificially increased blood pyruvate levels, pyruvate enters brain cells from extracellular space via 
MCTs, forcing the extrusion of lactate. Pyruvate entry and concurrent lactate exit via MCTs requires 
relatively high intracellular lactate levels.  
 
In summary, the genetically encoded lactate sensor Laconic in combination with 2PLSM was 
successfully applied to investigate brain energy metabolism at the single cell level in vivo for the first 
time. We demonstrate that neurons and astrocytes readily take up blood-borne lactate. Our data 
suggest a significantly lower baseline lactate level in neurons in comparison to astrocytes. Our findings 
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furthermore support the concept of compartmentalized lactate pools with a lactate flux from 
astrocytes to neurons.  
 
Experimental Procedures 
Viral constructs of the lactate sensor Laconic and the pyruvate sensor Pyronic  
Genetically-encoded FRET sensors for lactate (‘Laconic’; San Martín et al., 2013), and pyruvate 
(‘Pyronic’; San Martín et al., 2014), were cloned into adeno-associated viral (AAV) plasmids for 
astrocyte and neuron specific expression. The astrocyte-specific construct included a minimal GFAP 
promoter (GfaABC1D, sGFAP; kindly provided by Dr. M. Brenner, Department of Neurobiology, 
University of Alabama) (Lee et al., 2008), a beta-globin intron, and a poly-adenylation signal. The 
neuronal construct included a human synapsin-1 (SYN) promoter, a Woodchuck Hepatitis Virus (WHP) 
Post-transcriptional Regulatory Element (WPRE) and a poly-adenylation signal (Glover et al., 2002; 
Kügler et al., 2001). The four different shuttle plasmids (pAAV-SYN-Laconic, pAAV-GFAP-Laconic, pAAV-
SYN-Pyronic, and pAAV-GFAP-Pyronic) were used to generate AAV serotype 6 (SYN constructs) or AAV 
serotype 9 (GFAP constructs) viral particles, by co-transfecting the shuttle plasmid with the pDP6 and 
pDF9 helper plasmids in HEK293-AAV cells (Agilent Technologies, Santa Clara, CA). Viral particles were 
isolated from the cell lysates, using iodixanol step gradients and HPLC purification on heparin-binding 
(AAV6) and ion exchange (AAV9) columns. The number of viral genomic copies (VG) was measured by 
TaqMan real-time PCR, with primers amplifying specific sequences in the human beta-globin intron or 
WPRE element. 
Animals 
All experimental procedures were approved by the local veterinary authorities in Zurich and 
conformed to the guidelines of the Swiss Animal Protection Law, Veterinary Office, Canton of Zurich 
(Act of Animal Protection 16 December 2005 and Animal Protection Ordinance 23 April 2008). Surgery 
was performed in female wild type mice (C57BL/6J; Charles River) of 8 to 10 weeks of age (20 to 25 
gram bodyweight). The mice had free access to water and food and an inverted 12-hour light/dark 
cycle. 
Anesthesia 
The animals were anesthetized with a mixture of fentanyl (0.05 mg per kg bodyweight; Sintenyl, 
Sintetica, Switzerland), midazolam (5 mg per kg bodyweight; Dormicum, Roche, Switzerland) and 
medetomidine (0.5 mg per kg bodyweight; Domitor, Orion Pharma, Finland) intraperitoneally and 
anesthesia was maintained with midazolam (5 mg per kg bodyweight) subcutaneously after 50 
minutes. To prevent hypoxaemia, a face mask provided 300 mL/min of 100% oxygen. Core 
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temperature was kept constant at 37°C using a homeothermic blanket heating system during all 
surgical and experimental procedures (Harvard Apparatus, Holliston, MA, USA). The head was fixed in 
a stereotaxic apparatus and the eyes were kept wet with ointment (vitamin A eye cream; Bausch & 
Lomb, Switzerland).  
Virus injection 
 A 4x4 mm craniotomy was performed above the somatosensory cortex using a dental drill (Bien-Air, 
Bienne, Switzerland) and solutions containing virus vector were injected into the primary 
somatosensory cortex at a close distance to achieve neighboring, but non-overlapping, sensor protein 
expression: 75 nL of AAV9-GFAP-Laconic (titer 3.1E12 VG/mL); 150 nL of AAV6-SYN-Laconic (titer 
1.02E13 VG/mL) (San Martín et al., 2013); 75 nL of AAV9-GFAP-Pyronic (titer 1.6E12 VG/mL); 150 nL of 
AAV6-SYN-Pyronic (titer 1.15E12 VG/mL) (San Martín et al., 2014). Large vessels were avoided to 
prevent bleeding and the absorption of light by hemoglobin during imaging. A square cover slip (3x3 
mm, UQG Optics Ltd, UK) was placed on the exposed dura mater and fixed to the skull with dental 
cement, according to published protocols (Holtmaat et al., 2009). 
Head-post implantation  
A bonding agent (Gluma Comfort Bond; Heraeus Kulzer, Hanau, Germany) was applied to the cleaned 
skull and polymerized with a handheld blue light source (600 mW/cm2; Demetron LC, Switzerland). A 
custom-made aluminium head post was connected with dental cement (EvoFlow; Ivoclar Vivadent AG, 
Liechtenstein) to the bonding agent for later reproducible animal fixation in the microscopic setup. The 
skin lesion was treated with antibiotic ointment (Neomycin, Cicatrex; Janssen-Cilag AG, Switzerland) 
and closed with acrylic glue (Histoacryl, B. Braun, Germany). After surgery the animals were kept warm 
and provided with analgesics (metamizole 0.2 mg/g bodyweight; Sintetica, Switzerland) and an 
antibiotic was added to the drinking water (enrofloxacin, 200 mg/l drinking water; Baytril, Bayer, 
Germany). Sensor protein expression was checked using a fluorescence stereomicroscope (Leica MZ16 
FA) two to three weeks after virus injection and prior to imaging. 
Intracellular lactate measurements 
The mice were imaged using a custom-built two-photon laser scanning microscope (2PLSM) with a 
tunable pulsed laser (MaiTai eHP DS system, Spectra-Physics, CA, USA) at 870 nm wavelength and 
equipped with a 20x water immersion objective (W-Plan-Apochromat 20x/1.0 differential interference 
contrast, Zeiss, Germany). During measurements the animals were head-fixed and kept under the 
anesthesia described above. The galvo-mirrors and a motorized objective were used to cycle through 
two to four individual fields of view. Unidirectional frame scans at 0.1 Hz and 512x512 pixels resolution 
were acquired with ScanImage (r3.8.1; Janelia Research Campus; Pologruto et al., 2003)). Lactate 
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concentration in cultured cells were measured with the use of Laconic as previously described (Sotelo-
Hitschfeld et al., 2015). 
Extracellular lactate measurements 
Extracellular lactate measurements were performed with a commercially available recording system 
(Pinnacle Inc., Lawrence, KS, USA). Mice were fixed in a stereotactic frame under anesthesia (isoflurane 
1.5%; Abbott, North Chicago, IL, USA), the skull was opened with a dental drill, and a guide cannula 
(Part 7032, Pinnacle Technology, Lawrence, KS, USA) was implanted into the primary somatosensory 
cortex (from bregma: A/P +1.41, M/L -2.8, D/V -1.0) and fixed with dental cement to an anchor screw 
(Part 8209, Pinnacle Technology, Lawrence, KS, USA). After a recovery period of two weeks, the pre-
calibrated lactate biosensor was inserted into the guide cannula (Naylor et al., 2012). A tail vein 
catheter was inserted for saline, lactate and pyruvate infusions. Recording started after one hour of 
signal stabilization. 
Blood lactate level measurements 
The femoral artery was exposed and cannulated with fine bore polyethylene tubing (0.28 mm ID, 0.61 
mm OD, Portex, Smith medical, UK) to measure blood lactate level. Blood drops were removed from 
the cannula and every fourth drop was used for an enzymatic lactate assay (Lactate Pro 2, Arkray, 
Japan). After each blood sample analysis, the tubing was rinsed with heparinized (50 IU/ml) 0.9% saline 
solution. 
Intervention protocols 
For intravenous interventions, a 30 Gauge needle was connected to fine bore polyethylene tubing 
(0.28 mm ID, 0.61 mm OD, Portex, Smith medical, UK), filled with 0.9% saline solution and inserted into 
one of the tail veins. Before imaging, the tubing was connected via an X connector (model SC25, 
Instech, USA) to peristaltic pumps (Reglo digital ISM 831, Ismatec SA, Germany), which were operated 
via custom written Matlab codes. A 500 mM solution of sodium chloride (S7653, Sigma-Aldrich, MO, 
USA), sodium L-lactate (L7022, Sigma, MO, USA) or sodium pyruvate (P2256, Sigma-Aldrich, MO, USA) 
at 4 mmol per kg bodyweight was injected during 3 minutes.  
Immunohistochemistry 
Four mice expressing astrocytic and neuronal Laconic sensors and one mouse intraperitoneally 
injected with 2 mg per kg bodyweight lipopolysaccharides (Fontana et al., 1981) were anesthetized 
with pentobarbital (Nembutal, >50 mg/kg) intraperitoneally and transcardially perfused with 2% 
paraformaldehyde to assess immunohistochemical alterations. Brains were post-fixed in 4% 
paraformaldehyde, rinsed with phosphate-buffered saline (PBS), and cryoprotected with 30 % sucrose 
in PBS. The frozen brains were then cut into 40 µm sections with a sliding microtome and fluorescent 
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regions were identified with a fluorescence stereomicroscope (Leica MZ16 FA; Leica Microsystems, 
Germany). Free-floating sections were incubated with rabbit anti-Glial fibrillary acidic protein (GFAP) 
antibody (Z0334; DakoCytomation, DK), rabbit anti-fibrinogen antibody (A0080; DakoCytomation, DK) 
or rat anti-CD68 antibody (MCA1957GA; AbD Serotec) and stained with red-fluorescent secondary 
antibody (goat anti-rabbit and goat anti-rat Cy3; Jackson Immuno Research Laboratories Inc.). Images 
of the sections were collected with a laser-scanning confocal microscope (LSM510-Meta; Zeiss, 
Germany).  
Cell culture experiments 
All animal procedures for the cell culture experiments were approved by the Institutional Animal Care 
and Use Committee of the Centro de Estudios Científicos. Mixed cortical cultures of neuronal and glial 
cells were prepared from 1-3 day-old neonates (C57BL/6J) as detailed previously (Bittner, 2010). For 
Laconic sensor expression, cultures were exposed to 5 x 106 PFU of Ad Laconic and studied after 48 h 
(culture day 8-10). The co-culture cells were imaged with an upright Olympus FV1000 confocal 
microscope and a 440 nm solid-state laser as detailed previously (Sotelo-Hitschfeld et al., 2015). 
Masked ratio images were generated from background-subtracted images using ImageJ software. 
Data analysis and statistics 
Astrocytic domains and neuronal cytoplasm of individual cells of cortical layers L2/3 (150-250 µm 
below the dura) were outlined using ImageJ (1.46r; National Institutes of Health, USA). The mTFP 
channel (with bandpass filter 475/64; Semrock, USA) was divided by the Venus channel (with bandpass 
filter 542/50; Semrock, USA) and the ratio was normalized to the corresponding baseline or as 
indicated in the figure legend using Matlab (MathWorks, USA). Time acquisition curves are filtered 
with a moving average of five frames and indicated as mean ± standard deviation. Effects in multiple 
animals were compared using t-tests in R (R Core Team, 2014). P values < 0.05 were taken as 
significance limit. 
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Supplemental Figures 
 
Figure S1. Laconic immunohistochemistry and specificity. Related to Figure 1, 3 and 4. 
(A) Neuronal (left) and astrocytic (middle) Laconic fluorescence acquired post mortem using confocal 
microscopy. Cortical area without virus injection (right). Scale bar: 200 µm. (B) Both, astrocytic (blue 
frame) and neuronal (red frame) Laconic expressing tissue showed sparsely GFAP-positive astrocytes 
(arrows) without an increase compared to contralateral (gray frame) layer 2/3 cortex (image sections 
correspond to frame selections in panel A). The same GFAP staining was positive in mice injected with 
lipopolysaccharide (LPS, yellow frame), which is known to induce cortical inflammation (Fontana et al., 
1981). (C) Fibrinogen staining was restricted to vessels (arrows) without any sign of blood brain barrier 
leakage as in LPS treated mice. (D) Staining for CD68 did not indicate an increased number or reactivity 
of microglia as with LPS treatment (arrows). Scale bars in figures B-D: 50 µm. (E) The in vitro calibration 
curve of Laconic shows the substrate binding kinetics of lactate at 25° celsius (San Martín et al., 2013). 
(F) Increasing the output laser power from 4 to 59 mW (measured under the objective) increased the 
fluorescence intensity in the Venus and mTFP channel, but did not affect ratio values at laser intensities 
used in this study (20 to 40 mW, grey bar). In the rightmost subpanel, laser power values measured in 
a set of experiments with pyruvate infusions are indicated. (G) The intravenous injection of sodium 
chloride (4 mmol per kg bodyweight in three minutes, 500 mM solution) did not show different signal 
changes in astrocytes and neurons (n.s. = p > 0.05). (H) Ammonium chloride (NH4Cl) infusions over four 
minutes (2.5 mmol/kg bodyweight) increased Laconic signals in neurons and astrocytes (7.3 ± 1.3% vs. 
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7.4 ± 1.6%, respectively, normalization to baseline, mean of peak amplitudes, n.s. = p > 0.05). (I) 
Repetitive infusions of pyruvate (2 mmol per kg bodyweight in 1.5 minutes, 500 mM solution) were 
followed by the Laconic saturation protocol (ammonium chloride 4 mmol per kg bodyweight 500 mM 
solution mixed with lactate 8 mmol per kg bodyweight 1 M solution in 15 minutes). Normalization to 
the sensor’s saturation point demonstrates the convergence of astrocytic and neuronal Laconic under 
pyruvate induced trans-acceleration (upper traces). The simultaneous measurement of the pyruvate 
sensor Pyronic demonstrates the specificity of Laconic to lactate (lower traces). Data are represented 
as mean ± SD. 
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Figure S2. In silico modeling of trans-acceleration and in vitro controls. Related to Figure 2 and 5. 
Lactate and pyruvate are transported in and out of cells through monocarboxylate transporters 
(MCTs). Competition between the two substrates for the shared binding site in the transporter and the 
fact that the binding site trans-locates more efficiently when complexed with a substrate leads to 
trans-acceleration (also known as accelerated exchange (Garcia et al., 1994), that is the enhancement 
of transport of a substrate located at the opposite side of the membrane. Trans-acceleration can be 
explained with the following kinetic model: (A) Simulation results of intracellular lactate and pyruvate 
concentrations using kinetic parameters of the MCT 2 (4 µM; symmetrically distributed; pH 7.4; Koff 
lactate 7.6 x 106 s-1 and Koff pyruvate 7.6 x 105 s-1) during an extracellular 2 mM pyruvate challenge. 
Each line represents a different steady state lactate concentration from 0 to 1 mM at baseline. The 
rate of LDH is set to 10-4 s-1 and the reverse reaction 20 times lower, putting the ratio lactate/pyruvate 
to 20. (B) The same model as before but with the kinetic parameters of MCT 1 (20 µM; symmetrically 
distributed; pH 7.4; Koff lactate 7.6 x 107 s-1 and Koff pyruvate 7.6 x 106 s-1). (C) The contribution of LDH 
activity on pyruvate induced transients in the MCT 2 model is demonstrated for a wide range of LDH 
rates. (D) In the two MCT models, the amplitude of lactate depletion after 20 s depends linearly on the 
baseline lactate level and is larger with MCT 2 than MCT 1 (top). Pyruvate accumulates more in the 
MCT1 model (bottom). (E) Cultured neurons expressing Laconic showed pyruvate dose dependent 
lactate depletion (cells in a Krebs Ringer Hepes Bicarbonate buffer with 2 mM glucose and 1 mM 
lactate). (F) Cultured astrocytes in the same buffer solution showed similar Laconic transients. Data 
are represented as mean ± SD. (G) Under physiological conditions pyruvate concentrations are too low 
to compete with lactate at MCTs (left). After a rise in extracellular pyruvate (right part), the 
transporters bind pyruvate, which results in a reduced binding site availability for lactate and a 
reduction of lactate influx. Then the binding site trans-locates from outward-facing to inward-facing 
configuration. If there is lactate within the cell, the increased number of inward-facing sites 
subsequently causes an increased lactate efflux. The combination of reduced lactate influx and 
increased lactate efflux results in a drop of intracellular lactate concentration. This increase of lactate 
flux by pyruvate in this example is analogous to the extrusion of calcium by sodium in the Na+-Ca2+ 
exchanger.  
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Figure S3. Characterization of intracellular and extracellular lactate measurements. Related to Figure 
2, 3, 4 and 5.  
(A) and (B) demonstrate that the Laconic FRET ratio is independent from sensor expression levels. (A) 
A sample measurement from baseline (frame 10) from each cell imaged in this study was taken and 
the sum of the two channels was plotted against their ratio. (B) The same plot is given for cultured 
astrocytes. (C) Demonstration of reproducibility over different imaging sessions. Repetitive lactate 
infusions in a single mouse on day 1, 8 and 13 increased Laconic signals in variable populations of layer 
2/3 neocortical neurons and astrocytes. (D) Comparison of the in vitro pre- and post- calibration values 
from the extracellular lactate biosensors used in vivo demonstrates that the sensitivity of the sensor 
was preserved within an experiment. 
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Excitatory synaptic transmission is accompanied by a local surge in interstitial lactate that occurs despite adequate oxygen availability,
a puzzling phenomenon termed aerobic glycolysis. In addition to its role as an energy substrate, recent studies have shown that lactate
modulates neuronal excitability acting through various targets, including NMDA receptors and G-protein-coupled receptors specific for
lactate, but little is known about the cellular andmolecular mechanisms responsible for the increase in interstitial lactate. Using a panel
of genetically encoded fluorescence nanosensors for energymetabolites, we showhere thatmouse astrocytes in culture, in cortical slices,
and in vivomaintain a steady-state reservoir of lactate. The reservoir was released to the extracellular space immediately after exposure
of astrocytes to a physiological rise in extracellular K or cell depolarization. Cell-attached patch-clamp analysis of cultured astrocytes
revealed a 37 pS lactate-permeable ion channel activated by cell depolarization. The channel wasmodulated by lactate itself, resulting in
a positive feedback loop for lactate release. A rapid fall in intracellular lactate levels was also observed in cortical astrocytes of anesthe-
tized mice in response to local field stimulation. The existence of an astrocytic lactate reservoir and its quick mobilization via an ion
channel in response to a neuronal cue provides fresh support to lactate roles in neuronal fueling and in gliotransmission.
Key words: fluorescence microscopy; genetically encoded nanosensor; gliotransmission; membrane depolarization
Introduction
The discovery of surface lactate receptors in neurons and other
brain cells (Bozzo et al., 2013; Lauritzen et al., 2013; Tang et al.,
2014) has rekindled interest in the local extracellular lactate rise
that develops within seconds of neural activation (Prichard et al.,
1991; Hu and Wilson, 1997; Barros, 2013). Some of us have re-
cently proposed a mechanism contributing to the lactate tran-
sient that is based on the observation that a rise in extracellular
K ([K]o), such as that recorded during neural activity, stimu-
lates an astrocytic glucose consumption in culture and in brain
slices, which also occurs within seconds (Bittner et al., 2011; Ru-
minot et al., 2011). Exposure of astrocytes to elevated [K]o was
found to augment extracellular lactate, but, given the limited
temporal resolution of standard biochemical techniques, it was
not possible to ascertain whether K-stimulated astrocytes were
able to release lactate within seconds, the time frame of the
interstitial lactate transient observed in vivo. Genetically en-
coded nanosensors specific for nicotinamide adenine dinucle-
otide (NADH), lactate, and pyruvate, which were used here to
map the fate of glucose and lactate during the first seconds of
K stimulation, have been developed since then (Hung et al.,
2011; SanMartín et al., 2013, 2014a).We report that astrocytes
in vitro and in vivo maintain a cytosolic reservoir of lactate,
which, in response to plasma membrane depolarization, is
immediately released to the extracellular space via an ion
channel that conducts lactate and is positively modulated by
lactate itself.
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Materials andMethods
Standard reagents and inhibitors were acquired from Sigma. AR-C155858
was purchased fromHaoyuanChemexpress. Plasmids encoding the sensors
FLII 12Pglu7006 (Takanaga et al., 2008), Peredox (Hung et al., 2011),
Laconic (San Martín et al., 2013), and Pyronic (San Martín et al., 2014a)
are available from Addgene (www.addgene.org). Ad Laconic, Ad Py-
ronic, and Ad FLII 12Pglu7006 (all serotype 5) were custom made by
Vector Biolabs. The adeno-associated virus (AAV9) expressing Laconic
under the control of the short gfaABC1D promoter was generated at the
E´cole Polytechnique Fe´de´rale de Lausanne. Design, production, and
titration of the AAV9 vector for transgene expression in astrocytes have
been described previously (Dirren et al., 2014).
Animals
Animal procedures in Valdivia were approved by the Centro de Estudios
Científicos Animal Care and Use Committee, following the recommen-
dations of theGuide for the Care and Use of Laboratory Animals, Institute
of Laboratory Animal Resources, National Research Council. Animals
used were mixed F1 male mice (C57BL/6J6CBA/J), kept in an animal
room under specific pathogen-free conditions at a room temperature of
20  2°C, in a 12 h light/dark cycle with free access to food and water.
Surgical and experimental procedures in Zu¨rich were approved by the
local veterinary authorities, conforming to the guidelines of the Swiss
Animal Protection Law, Veterinary Office, Canton Zu¨rich (Act of Ani-
mal Protection 16 December 2005 and Animal Protection Ordinance 23
April 2008). Wild-type mice (C57BL/6J; Harlan Laboratories) 10 weeks
of age and with a body weight of 20 g were housed in single cages, with
water and food available ad libitum.
Experimental preparations
Culture cells. Mixed cortical cultures of neuronal and glial cells were
prepared from 1- to 3-d-old neonates (Loaiza et al., 2003). HEK293 cells
were cultured as previously described (SanMartín et al., 2013). HEK cells
and astrocytes were plasmid transfected (0.5g/ml) using Lipofectamine
2000 or 3000 (Life Technologies). Alternatively, astrocytes were exposed
to 5 106 pfu of Ad Laconic, Ad Pyronic, or Ad FLII 12Pglu7006, and
were studied after 48 h (culture days 8–10). Extracellular lactate levels
were measured with the BioVision Lactate Assay Kit according to the
instructions of the manufacturer.
Brain slices.Neonatal mice (days 1–3) were removed from the mother
and anesthetized by hypothermia over 15 min. Animals were positioned
upon a stage and injectedwith 1l of AAV9 (titer 3.1E12VG/ml) into the
skull (Davidson et al., 2010) using a Fusion 100 syringe pump (Chemyx).
After injection, the animals were positioned on a temperate bed until
they recovered and then returned to the mother. After 4 weeks, animals
were killed by cervical dislocation and coronal brain sections (200m in
thickness) were prepared as described previously (Jakoby et al., 2014).
Somatosensory cortex in vivo.Animals were anesthetized with an intra-
peritoneally injected mixture of fentanyl (0.05 mg/kg body weight; Sin-
tenyl, Sintetica), midazolam (5 mg/kg body weight; Dormicum, Roche),
and medetomidine (0.5 mg/kg body weight; Domitor, Orion Pharma),
and again after 50 min with midazolam only (5 mg/kg body weight). If
Figure 1. Astrocytes maintain a cytosolic lactate reservoir that is depleted in the short term by high [K]o. A, The FRET lactate sensor Laconic expressed in the cytosol of cultured astrocytes,
showingmTFP (blue), Venus (green), and the ratio betweenmTFP andVenus. Scale bar, 20m.B, Laconicwas first depleted of lactate by superfusionwith 10mMpyruvate (pyr), and then saturated
with 5 mM lactate and 2mM glucose (San Martín et al., 2013). C, Resting lactate level in 183 cells (17 experiments), estimated with the protocol in B. The top x-axis indicates lactate concentration,
according to the kinetic parameters estimated in vitro. Equilibrium concentration (MCTeq) of themonocarboxylate transporters.D, Response of intracellular lactate to 1M AR-C155858. The closed
symbol represents the average change after 5 min of MCT blockage. E, Effect of 0.5, 1, and 9 mM [K]o additions on the lactate level of an astrocyte. Resting [K
]o 3 mM. F, Initial rates of
K-induced lactate depletion. The open symbol represents the initial rate of lactate depletion after exposure to 3mM Ba 2.G–I, Effect of a 9mM [K]o rise on glucose consumption (G), cytosolic
NADH/NAD ratio (H ), and cytosolic pyruvate level (I ). J, Protoplasmic astrocytes expressing Laconic observed in an acute cortical slice at low (top) and high (bottom)magnification. Scale bar, 20
m. K, L, The effects of increasing [K]o by 9 mM (K ) or by adding 3 mM Ba
2 (L) on the lactate level of protoplasmic astrocytes are shown.
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necessary, anesthesia was prolonged with isoflurane (0.5%; Abbott). The
animal head was fixed in a stereotaxic apparatus (David Kopf Instru-
ments), and the eyes were kept wet with an ointment (vitamin A eye
cream; Bausch & Lomb). A 4 4 mm craniotomy was performed using
a surgical drill (Osseodoc) and 200 nl of recombinant AAV9 (titer 3.1E12
VG/ml), carrying the genetically encoded lactate sensor Laconic, was
injected into the primary somatosensory cortex. A square coverslip (3
3 mm, UQG Optics Ltd) was lightly pressed onto the exposed brain and
fixed with dental cement to the skull. A bonding agent (Gluma Comfort
Bond, Heraeus Kulzer) was applied to the cleaned skull and was polym-
erized with a handheld blue light source (600 mW/cm2; Demetron LC).
A custom-made aluminumheadpost was fixed to the bonding agent with
dental cement (Tetric EvoFlow, Ivoclar Vivadent). The open skin was
treated with an antibiotic ointment (Cicatrex, Janssen-Cilag) and closed
with acrylic glue (Histoacryl, B. Braun). After surgery the animals were
kept warm and given analgesics (Novaminsulfon, 50%, Sintetica), and
the antibiotic enrofloxacin was added to the drinking water for 5 d (200
mg/L drinking water; Baytril, Bayer).
Fluorescence imaging
Detailed protocols for the use of the fluorescent sensors are available
(Hou et al., 2011; Tantama et al., 2012; Barros et al., 2014; San Martín et
al., 2014b). In the article describing the lactate sensor Laconic (SanMar-
tín et al., 2013), data were presented showing some sensitivity to pH in
the alkaline range and also to citrate in the millimolar range. However,
further characterization has shown that the sensitivities to pH and citrate
were not a property of the sensor itself but in vitro artifacts respectively
due to protein instability at room temperature in a noncellular milieu
and divalent chelation by citrate. These results will be presented in detail
in a separate manuscript (San Martin et al., manuscript in preparation).
Measurements in cultured cells were performed at room temperature
(22–24°C) in a 95% air/5% CO2-gassed solution of the following com-
position (inmM): 112 NaCl, 3 KCl, 1.25 CaCl2, 1.25MgCl2, 1–2 glucose,
10 HEPES, and 24 NaHCO3, pH 7.4. Slice measurements were per-
formed at room temperature (22–24°C) in a 95% O2/5% CO2-gassed
solution of the following composition (in mM): 126 NaCl, 3 KCl, 1.25
NaH2PO4, 1.25 CaCl2, 1.25 MgCl2, 10 glucose, and 26 NaHCO3, at pH
7.4. Cells and slices were imaged with an upright Olympus FV1000 con-
focal microscope equipped with a 20 water-immersion objective (nu-
merical aperture, 1.0) and a 440 nm solid-state laser. Alternatively, cells
were imaged with Olympus IX70 or BX51 microscopes equipped with
Cairn Research monochromators and Optosplits, and either a
Hamamatsu Orca or Rollera camera. FLII 12Pglu7006, Laconic, and
Pyronic were excited at 430 nm for 0.2–0.8 s, andwere detected at 485/40
nm [cyan fluorescent protein or monomeric teal fluorescent protein
(mTFP)] and 535/30 nm (Citrine or Venus). Peredox-mCherry was im-
aged at 410 nmexcitation and 485/40 emission (T-sapphire), and 570 nm
excitation and 610/50 nm emission (mCherry). Masked ratio images
were generated from background-subtracted images using ImageJ soft-
ware. The H-sensitive dye 2,7-bis-(2-carboxyethyl)-5-(and-6)-
carboxyfluorescein (BCECF) was ester loaded at 0.1M for 3–4min, and
the signal was calibrated by exposing the cultures to solutions of different
pH after permeabilizing the cells with 10 g/ml nigericin and 20 g/ml
gramicidin in an intracellular buffer. BCECF was sequentially excited at
440 and 490 nm (0.05 s), and imaged at 535/30 nm. Calcein was ester
loaded at 0.1M for 20min and then imaged using confocal microscopy.
After 3 weeks of sensor expression, living mice were imaged with a
custom-built two-photon laser-scanning microscope using a tunable
pulsed (Mai Tai eHP DS system, Spectra-Physics) at a wavelength of 870
nm using a 20water-immersion objective (W Plan-Apochromat 20/
1.0 differential interference contrast, Zeiss). The animals were head fixed
and kept under anesthesia, as described above. Body temperature was
kept constant with a feedback-controlled heating pad (37°C; Harvard
Apparatus). Frame scans were acquired with ScanImage (r3.8.1; Janelia
ResearchCampus; Pologruto et al., 2003) at 1.63Hz and 512 512 pixels
resolution. Single astrocytes of cortical layers L2/3 (150–250 m below
the dura) were outlined using ImageJ (1.46r; National Institutes of
Health) and the mTFP channel (with bandpass filter 475/64; Semrock)
Figure 2. Intracellular lactate accumulation in response to OXPHOS inhibition. Astro-
cytes were exposed to 5 mM azide while measuring glucose, NADH/NAD ratio, pyruvate
or lactate. The effect of 12 mM [K]o on pyruvate levels (from Fig. 1I ) is shown for
comparison.
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was divided by the Venus channel (with bandpass filter 542/50; Sem-
rock), and the ratio was normalized to the corresponding baseline using
Matlab (MathWorks). Glass capillaries (Science Products; GB120F-8P
0.69  1.20  80 mm with filament) were pulled to achieve an imped-
ance of 1.5M at 1 kHz (P-87 pipette puller, Sutter Instrument Co.) and
were filled with an artificial CSF solution of the following composition
(in mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 25 glucose, 1.25
NaH2PO4, and 25 NaHCO3, pH 7.4 (Laboratorium Dr. Bichsel AG,
Interlaken, Switzerland). The glass of the cranial window was split using
a diamond glass cutter and was partially removed. The pipette was
mounted on a manipulator (SM-5, Luigs & Neumann) inserted under
visual control and left to rest for 60 min before imaging. Intracortical
microstimulation was applied with a DC cathodal current of 100 A for
1 min (1 Hz train frequency, 100 ms trains at 330 Hz, 0.26 ms pulse
width) using a constant-current isolator (STG 4002, Multi Channel
Systems).
Electrophysiology
Culture dishes containing cortical astrocytes were transferred to the stage
of an inverted microscope for study. They were continuously superfused
with a bathing solution containing the following (in mM): 136 NaCl, 3
KCl, 1.25MgCl2, 1.25 CaCl2, 2.0 Glucose, 1.0NaLactate, and 10HEPES-
Tris, at pH 7.4 and osmolality of 300 mOsm. The pipette solution con-
tained the following (in mM): 145 NaLactate, 1.0 NaCl, 3.0 KCl, 3.0
BaCl2, and 10 HEPES-Tris 10 mM, at pH 7.4 and osmolality of 300
mOsm. Recordings of single channels in the cell-attached patch-clamp
configuration were performed using 6- to 12-d-old astrocytes. Patch
pipettes made from borosilicate glass were fire polished and covered in
beeswax, and had a tip resistance of 3–4M (measured using the pipette
solution described above). After obtaining G seals, currents were mea-
sured using a List Medical L/M-EPC5 amplifier. An Ag/AgCl pellet acted
as a bath ground and was connected to the bathing solution via a 0.5 M
KCl agar bridge. Potentials were corrected for liquid junction shifts
(Barry, 1994). Acquisition and analysis were
performed with a Digidata 1200A analog-to-
digital converter and Clampfit version 9.0 soft-
ware (Molecular Devices). Acquisition was at
10 kHz with a filter (four-pole Bessel filter) at 3
kHz. Experiments were conducted at room
temperature (20–24°C). NPo, where N is the
number of active channels in the membrane
patch and Po is the open probability, was calcu-
lated using the single-channel search and event
statistics algorithms in pClamp version 9.0
software. The mean current I passing through
the N channels present in the patch was esti-
mated from current amplitude histograms.
Single-channel conductance estimates were
made on the assumption that astrocytes had a
membrane potential Em of	80 mV (Ruminot
et al., 2011). Intracellular lactate concentration
was assumed to be 1.4 mM. An intracellular
chloride concentration of 30 mM was assumed
(Bekar and Walz, 2002). We used these con-
centrations to calculate cell-attached patch re-
versal potential Erev values of 27 and	116mV,
respectively, for chloride and lactate.
Data presentation and statistical analysis
Line traces represent individual cells. Unless
otherwise stated, traces with error bars corre-
spond to the mean  SEM of eight or more
cells (n 3 experiments). Differences in mean
values of paired samples were evaluated with
the Student’s t test. p values of
0.05 were con-
sidered significant and are indicated with an
asterisk (*).
Results
Resting astrocytes maintain a standing lactate reservoir
Astrocyte lactate dynamics were monitored in real time with La-
conic, theForster resonanceenergy transfer (FRET) lactatenanosen-
sor (SanMartínet al., 2013;Fig. 1A).Toestimate resting lactate levels
in cultured astrocytes, cells were first emptied of lactate by acceler-
ated exchangewithpyruvate and then exposed to saturating levels of
lactate, a two-point calibration protocol that has been described in
detail previously (San Martín et al., 2013). With this approach, the
sensor was found to be close to saturation in most astrocytes (Fig.
1B,C).Using the kinetic parameters obtained in vitro (SanMartín et
al., 2013), the average concentration of cytosolic lactate was esti-
mated to be 1.4 0.02 mM (n 183 cells in 17 experiments). The
transport of lactate across the astrocytic plasmamembrane is medi-
ated by monocarboxylate transporters (MCTs) that catalyze the
electroneutral cotransport of a lactate anion and anH ion.With 1
mM lactate in the superfusate at a pHof 7.4, and amean intracellular
pHof7.20.02(n43cells3experiments),MCTs inastrocytesare
at thermodynamic equilibriumat 0.63mMintracellular lactate ([lac-
tate]o [H
]o [lactate]i [H
]i). As shown in Figure 1C, 88%
of the astrocytes maintained cytosolic lactate levels above equilib-
rium in the resting condition. MCT blockage with AR-C155858
(Ovens et al., 2010) led to further intracellular lactate accumulation
(Fig. 1D), providing independent evidence that restingastrocytes are
tonic lactateproducers thatkeep lactateabove theMCTequilibrium.
Depolarization by high [K]o depletes astrocytic lactate
A rise in [K]o has been reported to stimulate astrocytic glucose
consumption, glycogen mobilization, and lactate production in
cell cultures and in tissue slices (Hof et al., 1988; Bittner et al.,
Figure 3. Early depletion of astrocytic lactate during local electrical stimulation in vivo. The strength of electrical stimulation
was modulated by varying the distance between cells and the tip of the stimulation pipette, giving a weaker stimulation at
300–500manda stronger stimulation at 20–200m.A, Imagingof Laconic expressed in somatosensory cortex astrocytes. The
location of the stimulation pipette is indicated. Scale bar, 20m. B, Data from a single experiment. C, Early response to weaker
(n 3 experiments) and stronger stimulation (n 7 experiments). D, Extended time course for stronger stimulation (n 7
experiments) E, Left, Intracellular lactate level in cultured astrocytes exposed first to a 9mM increase in [K]o, and 30 s later, to a
rise in extracellular lactate level from 1 to 5 mM. Right, Data from three cells from the same field (black) are compared with the
average depletion elicited by a 9 mM [K]o increase at constant extracellular lactate concentration of 1 mM (white).
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2011; Ruminot et al., 2011; Choi et al., 2012; Sotelo-Hitschfeld et
al., 2012). Therefore, we expected to find increased cytosolic lac-
tate levels inK-stimulated astrocytes. Paradoxically, high [K]o
led to depletion of the cytosolic lactate reservoir (Fig. 1E). The
phenomenon was evoked with 4 mM K, a mere 1 mM over
resting [K]o (Fig. 1E,F) and within the range reported in brain
interstice during physiological neural activity (Fro¨hlich et al.,
2008). The effect of K was mimicked by Ba2 (Fig. 1F), which
depolarizes the plasmamembrane by blocking K channels (Ru-
minot et al., 2011). As reported (Bittner et al., 2011), the mea-
surement of glucose consumption by applying a glucose
transporter GLUT blocker (Bittner et al., 2010) to astrocytes ex-
pressing the glucose nanosensor FLII12Pglu7006 (Takanaga et
al., 2008) showed that high [K]o stimulated glycolysis by
300% (Fig. 1G). Consistent with an increased glycolytic rate,
Peredox (Hung et al., 2011) showed an increased NADH/NAD
ratio (Fig. 1H). However, Pyronic (San Martín et al., 2014a) re-
vealed that cytosolic pyruvate concentrations increased slightly
and only after a delay of 30 s (Fig. 1I). The weak response of
pyruvate to such strong glycolytic activation is consistentwith the
Figure 4. Fast astrocytic lactate release detected with a lactate sniffer. A, HEK293 cells expressing Laconic (sniffers) were seeded on top of an astrocytic culture and imaged by 3D confocal
microscopy (green). A second 3D reconstruction was performed after ester loading the culture with calcein (gray). B, Response of a sniffer positioned on top of an astrocytic culture to increasing
concentrations of [K]o (4, 6, and12mM), 3mMBa
2, 1mM lactate, and10mMpyruvate. Theexperimentwasperformed in2mMglucose and0mM lactate.C, Typical responseof sniffers to astrocytic
culture exposure to 12mMK.D, Correlation between the amplitude and the initial rate of the response of the sniffer to 12mMK. E, Astrocytic lactate depletion by 12mMK in the absence (gray
symbols and bars) and presence (white symbols and bars) of 1M AR-C155858.
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simultaneous operation of a lactate dehydrogenase (LDH)-
mediated pyruvate sink driven by the lactate depletion and
NADH increase. The phenomenon of lactate depletion seemed
specific to high [K]o, as the inhibition of oxidative phosphory-
lation (OXPHOS),which also stimulated glycolysis and increased
the cytosolic NADH/NAD ratio, led to the expected immediate
accumulation of both pyruvate and lactate (Fig. 2). To study
astrocytes in the tissue context, a recombinant adeno-associated
virus coding for Laconic under the short gfaABC1D promoter
was stereotaxically injected into the brain of neonatal mice, fol-
lowed by cortical slice preparation and FRET determinations 4
weeks later. As illustrated in Figure 1J–L, when the slice was ex-
posed to high [K]o or Ba
2, protoplasmic astrocytes responded
with a lactate depletion similar to that observed in culture. Con-
sidering the responses in cultured cells and in tissue slices of
lactate, glucose, NADH/NAD ratio, and pyruvate, we hypoth-
esized that astrocytic depolarization by high [K]o stimulated
lactate release to a larger extent than glycoytic lactate production.
Lactate dynamics in vivo
The lactate sensor was expressed in astrocytes of the primary
somatosensory cortex of adult mice using the adeno-associated
viral vector and was then imaged under anesthesia through a
cranial window with two-photon microscopy (Fig. 3A). Local
field stimulation that increases [K]o in vivo and depolarizes
astrocytes within seconds (Chesler, 2003; Fro¨hlich et al., 2008)
elicited a complex astrocytic lactate response. Immediately after
the onset of stimulation, there was a fast transient decrease, fol-
lowed by an overshoot and a secondary decrease despite contin-
ued stimulation (Fig. 3B). The lactate dip does not seem to arise
from a stimulation artifact, as astrocytes located near the stimu-
lation pipette showed a smaller dip (Fig. 3C). This stronger stim-
ulation provoked a faster and larger overshoot that maintained
cytosolic lactate above baseline levels long after stimulation had
ended (Fig. 3D). Whereas electrical stimulation may affect me-
tabolism by several mechanisms, a possible interpretation for the
complex response observed in vivo is that the initial lactate dip is
mediated by high [K]o, as observed in vitro, and that the over-
shoot reflects the interstitial lactate buildup known to occur in
vivo. Consistent with this explanation, both dip and overshoot
could bemimicked in cultured astrocytes by elevating extracellu-
lar lactate levels a few seconds after the application of K (Fig.
3E). The effect of adding lactate was variable from cell to cell,
ranging from a slight decrease in the rate of lactate depletion to a
proper overshoot (Fig. 3E). In viewof the results described below,
this is likely explained by variable balancing between MCT-
mediated lactate influx and channel-mediated lactate efflux.
Astrocytes release lactate within seconds of
membrane depolarization
Augmented lactate efflux in response to astrocyte depolarization
was first confirmedwith an enzymatic assay, which showed that a
1 min exposure of cultured astrocytes to 12 mM [K]o increased
extracellular lactate by 69 7%. For better temporal resolution,
Figure 5. A lactate-permeable channel modulated by membrane depolarization and lactate. A, Traces obtained under lactate-rich (145mM) and chloride-low (10mM) pipette conditions in the
cell-attachedmode at 100 and40mVapplied potential.B, Left, Recording fromanastrocyte patchheld at 0mV (80mVapplied potential) before andduring exposure of the cell to 3mMBa 2. Right,
The channel activity in eight similar experiments is illustrated as NPo, the product of the number of channels in the patch and the open probability of each channel. C, Left, Effect of increasing bath
lactate concentration from 1 to 10mM on channel activity. Right, Summary of four similar experiments.D, A cell was sequentially bathedwith 3mM Ba 2 and/or 10mM lactate for periods of 5min
as shown.
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a lactate-sniffer cell was engineered by ex-
pressing Laconic in wild-type HEK293
cells, which are MCT rich (San Martín et
al., 2013, 2014a) and insensitive to glyco-
lytic modulation by K (Ruminot et al.,
2011). To estimate lactate levels in the im-
mediate vicinity of astrocytes, lactate
sniffer cells were seeded on top of
the astrocytic monolayer (Fig. 4A).
Within seconds of exposing the cultures
to elevated [K]o or Ba
2 level, the sniff-
ers detected a higher extracellular lactate
(Fig. 4B). The typical response was a rapid
rise to a new steady state, which reverted
to baseline levels after agonist removal, al-
though we saw considerable cell-to-cell
variability (Fig. 4C,D). Control experi-
ments in the absence of astrocytes showed
that intracellular lactate in HEK293 cells
was insensitive to 12 mM [K]o or 3 mM
Ba2 (data not shown). These results in-
dicate that astrocytes release lactatewithin
seconds of membrane depolarization,
thus explaining the intracellular depletion
despite glycolytic stimulation. Next, we
focused on the mechanisms underlying
the lactate release, with first possible can-
didates being MCTs. However, the MCT
blocker AR-C155858, which abrogates
lactate permeation in these cells (San
Martín et al., 2013, 2014a), had no appar-
ent effect on the lactate depletion (Fig.
4E), pointing to the existence of an alter-
native release pathway.
Channel-mediated lactate release
by astrocytes
Our search for a lactate conductance
started with whole-cell patch-clamp ex-
periments, but no significant currents
could be detected with a lactate-rich pi-
pette at resting membrane potential or
during depolarization (n  6 experi-
ments, data not shown). Experiments
were therefore performed in the cell-
attached configuration, a minimally invasive approach that
leaves the intracellular milieu unperturbed, using a pipette solu-
tion rich in lactate, low in chloride, and supplemented with 3mM
Ba2 to eliminate the potassium conductance (Ruminot et al.,
2011). Assuming intracellular concentrations of 1.4 mM for lac-
tate (see above) and of 30 mM for chloride (Bekar and Walz,
2002), approximate lactate reversal potential Elactate and chloride
reversal potential ECl values are 	116 and 27 mV, respectively.
Records obtained under these conditions at an applied potential
of 100 mV revealed transient outward currents consistent with
ion channel activity (Fig. 5A). At an astrocytic membrane poten-
tial of 	80 mV (Ruminot et al., 2011), this applied potential
translates into a nominal patch potential of 20 mV, which is well
above Elactate but below ECl. The only ion species capable of car-
rying this current is lactate, as chloride and sodium movements
would generate inward currents. Accordingly, the currents be-
came progressively smaller at more negative potentials (Figs. 5A,
6). Small inward currents were detected at a nominal patch po-
tential of	80mV (Fig. 6), suggesting that the channel also allows
chloride to pass. For simplicity, we will use the term “lactate
channel” to refer to this lactate-permeable channel. At a 40 mV
nominal patch potential, the single-channel conductance of the
lactate channel was 37 6 pS (n 6). Currents were detected in
50% of the patches examined. It was not possible to test the
effect of cell depolarization with high [K]o, as this maneuver
destabilized the patch and prevented reliable current determina-
tions. However, cell depolarization by adding Ba2 to the super-
fusate stabilized the patch, permitting prolonged experiments to
be performed. Within seconds of exposure to Ba2, the open
probability of the channel became significantly higher regardless
of basal activity (Fig. 5B). Surprisingly, the activity of the channel
was further increased when cells were superfused with a solution
containing a higher concentration of lactate (Fig. 5C). The stim-
ulatory effects of Ba2 and lactate on channel activity were addi-
tive and reverted upon removal from the bathing solution, but
Figure 6. Further characterization of the lactate-permeable channel.A, Traces obtainedwith a lactate-rich (145mM), chloride-
low (10 mM) medium, with pipette in the cell-attached mode at 120, 100, 60, and 0 applied potential. B, Single-channel current
obtained at increasing nominal patch potentials (calculated assuming an astrocytic membrane potential of	80 mV). The equi-
librium potentials estimated for lactate and chloride are indicated. C, A cell was sequentially bathed with 10mM lactate and 3mM
Ba 2 for periods of 5 min as shown.
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this reversion was partial, at least over a period of minutes (Figs.
5D, 6).
MCTs are responsible for the lactate permeability of resting
astrocytes (Barros and Deitmer, 2010; Bouzier-Sore and Pellerin,
2013; Stobart and Anderson, 2013). The high permeability of
astrocytes to lactate is illustrated in Figure 7A as a rapid accumu-
lation of cytosolic lactate in response to high extracellular lactate.
However, when high lactate was applied in the presence of high
[K]o, the rise in lactate was smaller than that seen under resting
conditions (Fig. 7A,B). In50% of cells, the 5 mM lactate pulse
provoked intracellular lactate depletion (Fig. 7A,B). The latter
result is highly informative as it means that despite high levels of
extracellular lactate, efflux through the channel may still surpass
influx throughMCTs. It also means that the positive modulation
of the channel by lactate, as described electrophysiologically,
must occur at an extracellular site. The cell-attached configura-
tion is not amenable to pharmacological characterization, so we
used the initial depletion detected with the FRET nanosensor as a
readout of channel activity. Considering the negative charge of
lactate and the possible chloride current detected at 0mV applied
potential (Fig. 6), we tested a panel of anion channel blockers but
found that only Cd2 was able to inhibit K-induced lactate
depletion to a significant extent (Fig. 7C). The pannexin channel
blocker probenecid and the connexin hemichannel blocker CBX
were not effective (Fig. 7C). On closer inspection, it became ap-
parent that Cd2 strongly inhibited lactate depletion immedi-
ately after the application of K or Ba2, but that its effect
became weaker over time (Fig. 7D). This suggests that there may
be more than one pathway involved, and that the Cd2-sensitive
channel is responsible for the early phase of the lactate release.
Discussion
Themain finding of this study is that astrocytes release lactate via
an ion channel in response to a small rise in extracellular K. The
lactate-permeable channel was positively modulated by lactate
itself. Resting astrocytes were found to accumulate lactate well
above MCT thermodynamic equilibrium: a dynamic reservoir
that was quickly mobilized in response to high [K]o. Astrocytes
are therefore equipped with a mechanism for the targeted deliv-
ery of lactate, which fits well to the emerging role of lactate as a
signaling molecule (Fig. 8).
The transport of lactate across the plasmamembrane of astro-
cytes and most other mammalian cells is mediated by H-
coupled monocarboxylate transporters (Halestrap and Price,
1999; Barros andDeitmer, 2010; Bouzier-Sore and Pellerin, 2013;
San Martín et al., 2013; Stobart and Anderson, 2013). Standard
uptake assays based on isotopic tracers or pH-sensitive dyes show
that lactate permeability of astrocytes is high, and no significant
lactate gradients have been presumed to exist across the plasma
membrane. With the FRET nanosensor, we were able to estimate
lactate in the steady state and found that most astrocytes main-
tained lactate levels above thermodynamic equilibrium. In re-
Figure 7. Stimulated astrocytes can extrude lactate against a lactate gradient.A, Astrocytes were sequentially exposed to 10mM pyruvate and then to 5 and 10mM lactate in the presence of 3 or
12 mM [K]o. B, Summary of three similar experiments showing the initial rates of 5 mM lactate accumulation in 3 or 12 mM [K
]o. C, Left, The effect of a 9 mM increase in [K
]o on intracellular
lactatewasmonitored in a single astrocyte before and during exposure to 200MDIDS. Right, Summary of similar experiments,with 200MDIDS, 500MNFA, 500MNPPB, 200M Cd 2, 1mM
probenecid, or 10M CBX. Data are the rates of lactate depletion measured over 2 min (n 3 experiments and 16–32 cells were used for each inhibitor). D, Top, The effects of a 9 mM increase in
[K]o or the addition of 3 mM Ba
2 on intracellular lactate level were monitored in single astrocytes before and during exposure to 200M Cd 2. Bottom, Initial rates measured during the first
minute of exposure to [K]o or 3 mM Ba
2 in the absence or presence of 200M Cd 2.
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sponse to high [K]o cytosolic lactate
levels fell despite strong concurrent stim-
ulation of glucose consumption. Pyruvate
levels were almost unaffected, suggesting
a close match between increased pyruvate
production from glucose and pyruvate
consumption by LDH, driven by a lower
lactate level and an increased NADH/
NAD ratio. The K-dependent lactate
depletion appears to be a robust phenom-
enon, as it was observed in both primary
cultures and in protoplasmic astrocytes of
adult brain slices. It has also been re-
corded in organotypical hippocampal
slices (I. Ruminot and J.W. Deitmer, un-
published data). Also, within seconds of
K stimulation, a sniffer cell detected the
release of lactate by astrocytes. Both lac-
tate depletion and release were mimicked
by Ba2, a maneuver that does not engage
K transporters (Gatto et al., 2007), sug-
gesting that the phenomenon is chiefly
mediated by membrane depolarization.
In living animals, electrical stimulation of
the somatosensory cortex triggered a
complex astrocytic lactate response, with
an initial dip and a delayed overshoot. As
lactate modulates astrocytic glycolysis
within seconds (Sotelo-Hitschfeld et al.,
2012), the lactate dip may contribute to
the stimulation of glycolysis by high
[K]o. Although the depletion phase of
the lactate dip observed in protoplasmic
astrocytes in vivo correlates with the K-
dependent depletion observed in cultured
astrocytes and in protoplasmic astrocytes
in vitro, and we couldmimic both dip and
overshoot under culture conditions, the extent to which the lac-
tate dip in vivo is mediated by K is not clear at this stage. Elec-
trical stimulation increases interstitial K and depolarizes
astrocytes (Fro¨hlich et al., 2008), but also mobilizes other medi-
ators that may affect lactate metabolism. The combination of cyto-
solic depletion and release is evidence of increased lactate
permeability, anoutcome that couldnot be ascribed to theMCTs, as
pharmacological MCT blockage failed to prevent lactate depletion.
Both the depletion of cytosolic lactate by high [K]o and the further
depletion during a lactate pulse could be explained by the electro-
physiological detection of a lactate-permeable ion channel, having
an open probability increased by plasma membrane depolarization
andby lactate. The lactate channelwasnot detected in thewhole-cell
configuration, suggesting the need for an intact intracellular
milieu. Considering that the application of high lactate con-
centrations to K-stimulated cells caused a decrease in intra-
cellular lactate levels, the modulation of the channel by lactate
seems to occur at the cell surface. One possible explanation
may be direct gating of the channel by the permeant ion, a
phenomenon that has already been described for anion chan-
nels (Pusch and Jentsch, 1994; Catala´n et al., 2004).
To the best of our knowledge, there are no previous reports of
lactate-permeable ion channels in astrocytes. The lactate-
permeable channel of astrocytes was insensitive to 4,4-
diisothiocyano-2,2-stilbenedisulfonic acid (DIDS), niflumic
acid (NFA), 5-nitro-2-(3-phenylpropylamino)benzoic acid
(NPPB), probenecid, and carbenoxolone (CBX), but was par-
tially inhibited by Cd2, a nonspecific ion channel inhibitor.
Anion channels are notoriously insensitive to inhibitors (Kimel-
berg et al., 2006), which has made it very difficult to link func-
tionally identified anion channels to their molecular
counterparts (Jentsch et al., 2002). However, a breakthrough was
made recently with the molecular identification of the volume-
regulated anion channel VRAC (Qiu et al., 2014; Voss et al.,
2014). Anion channels in astrocytes are stimulated by ATP, cell
swelling, shape changes, and other stimuli (Kimelberg et al.,
2006), but we found no information on astrocytic anion channels
activated by cell depolarization. Thismay be because electrophys-
iological measurements are normally performed in whole-cell
voltage clamp, a configuration in which the lactate channel did
not appear. It was, however, readily found in the cell-attached
patch-clamp configuration, suggesting the need for a cytosolic
factor that may be lost during dialysis. The main substrate of
anion channels is chloride, but some of these channels may also
transport large zwitterionic polyions such as taurine (125Da;Qiu
et al., 2014; Voss et al., 2014), and are therefore likely to transport
lactate, a smallermonovalent anion (88Da). Lactate has not been
routinely included in selectivity studies of anion channels. The
maxi-anion channel is present in astrocytes (Kimelberg et al.,
2006), but its conductance seems too large (300 pS for chloride,
and presumably 100 pS for lactate) to account for the lactate
permeability described here. Conductance may also be invoked
Figure 8. Activity-dependent channel-mediated lactate release by astrocytes. Resting astrocytesmaintain a standing reservoir
of cytosolic lactate, the result of a dynamic balance between glycolytic production and MCT-mediated lactate export. Active
neurons release K, which depolarizes the astrocytic plasma membrane (Vm) and activates the lactate-permeable channel,
resulting in lactate release, leading to higher [lactate]o and further lactate release through a positive feedback. Neuronsmay sense
lactate through HCA1 (Bozzo et al., 2013; Lauritzen et al., 2013) and other surface lactate receptors (Tang et al., 2014), or after
internalization of lactate via MCTs.
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against connexins and pannexins (200 pS; Giaume et al., 2013),
together with the observed insensitivity of the lactate channel to
carbenoxolone and probenecid, and the fact that connexins and
pannexins are permeable to cations.
An activity-dependent lactate channel in astrocytes has con-
sequences for brain lactate dynamics. There are fundamental dif-
ferences between the standard transport of lactate via MCTs and
transport via an ion channel; one of these is vectorial flux. Lactate
is a monovalent anion, and at the resting membrane potential of
astrocytes (	80mV) lactatewill flow through the channel against
a 20-fold chemical gradient. At 12 mM [K]o, the membrane
potential of a “depolarized” astrocyte is still	60mV (Ruminot et
al., 2011), a voltage at which channel-mediated efflux will occur
against a 10-fold chemical gradient. This explains how an im-
posed fivefold rise in extracellular lactate failed to increase intra-
cellular lactate levels in K-stimulated astrocytes (Fig. 3E). In
contrast, MCT-mediated transport is electroneutral and may
only extrude lactate if there is a favorable combined chemical
gradient for lactate and H. During neural activity, astrocytes
become more alkaline and neurons acidify (Chesler, 2003), a
combination that works against the transfer of lactate from astro-
cytes to neurons (Barros and Deitmer, 2010). Using a pathway
that is H independent and sensitive to membrane potential,
astrocytes may push lactate toward neurons regardless of the pH
gradient, even if lactate has accumulated in the interstice. An-
other relevant property of channels is their unmatched through-
put rate. Assuming linear dose dependence, we can calculate that
a single 37 pS channel (adjusted at 1.4 mM and 	60 mV) con-
ducts105 lactatemolecules per second, about a thousand times
faster than the maximum turnover number of MCT1 (Ovens et
al., 2010). Astrocytic lactate has been proposed to serve as an
energy substrate for active neurons, a mechanism known as the
astrocyte-to-neuron lactate shuttle (ANLS; Pellerin and Magis-
tretti, 1994; Bouzier-Sore and Pellerin, 2013; Stobart and Ander-
son, 2013). In its standard version, ANLS is mediated by MCTs,
and therefore the direction of flux is determined by the lactate
gradient between both cells, which is unknown (Barros and Dei-
tmer, 2010). The lactate channel strengthens the ANLS by pro-
viding obligatory vectorial flux (energized by the astrocytic
membrane potential), activity dependence (mediated by [K]o),
and a much higher throughput rate.
In addition to a role in neurometabolic coupling, the lactate
channel may contribute to intercellular signaling. The Gi-
protein-coupled receptor for lactateHCA1 (GPR81) was recently
described in synaptic regions, perivascular locations, and glia
(Bergersen and Gjedde, 2012; Lauritzen et al., 2013), whereas the
engagement ofHCA1 in cortical neurons in culture reduced their
spontaneous activity (Bozzo et al., 2013). In the locus ceruleus,
astrocytic lactate was found to excite neurons, a phenomenon
mediated by a different surface lactate receptor (Tang et al.,
2014). After entering neurons, lactate affects pH, the NADH/
NAD ratio, and the energy status, modulating enzyme catalysis,
gene expression, and higher-order brain functions like memory
consolidation (Gilbert et al., 2006; Suzuki et al., 2011; Barros,
2013; Yang et al., 2014). Because of the delicate geometry of pro-
toplasmic astrocytes, their membrane potential is thought to be a
local parameter, exquisitely sensitive to fluctuations in [K]o
(Kofuji and Newman, 2004; Fro¨hlich et al., 2008; Witthoft et al.,
2013). Depending on location, the lactate channel may sense the
local rise in [K]o that accompanies excitatory neurotransmis-
sion and perhaps the activity of the nodes of Ranvier, which are
contacted by astrocytic processes. A single channel may deliver
lactate transiently as a localized jet, permitting accurate homing
of targets in neighboring cells and/or in autocrine fashion. The
amplification conferred by the positive feedback modulation of
the channel by lactate is expected to make the release even more
abrupt. Astrocytes detect synaptic activity through metabotropic
and ionotropic glutamate receptors, leading to the release of glu-
tamate, ATP, and D-serine, small neuromodulators that are col-
lectively termed gliotransmitters (Araque et al., 2014). Astrocytes
can also detect synaptic activity through changes in local [K]o.
The neuromodulatory roles of lactate, its steady-state reservoir in
astrocytes, and its fast release in response to K, suggest that
lactate may also qualify as a gliotransmitter.
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Neural activity is accompanied by a transient mismatch between local
glucose and oxygen metabolism, a phenomenon of physiological and
pathophysiological importance termed aerobic glycolysis. Previous
studies have proposed glutamate and K+ as the neuronal signals that
trigger aerobic glycolysis in astrocytes. Here we used a panel of ge-
netically encoded FRET sensors in vitro and in vivo to investigate the
participation of NH+4 , a by-product of catabolism that is also released
by active neurons. Astrocytes in mixed cortical cultures responded to
physiological levels of NH+4 with an acute rise in cytosolic lactate
followed by lactate release into the extracellular space, as detected
by a lactate-sniffer. An acute increase in astrocytic lactate was also
observed in acute hippocampal slices exposed to NH+4 and in the
somatosensory cortex of anesthetized mice in response to i.v. NH+4 .
Unexpectedly, NH+4 had no effect on astrocytic glucose consumption.
Parallel measurements showed simultaneous cytosolic pyruvate accu-
mulation and NADH depletion, suggesting the involvement of mito-
chondria. An inhibitor-stop technique confirmed a strong inhibition of
mitochondrial pyruvate uptake that can be explained by mitochon-
drial matrix acidification. These results show that physiological NH+4
diverts the flux of pyruvate from mitochondria to lactate production
and release. Considering that NH+4 is produced stoichiometrically with
glutamate during excitatory neurotransmission, we propose that
NH+4 behaves as an intercellular signal and that pyruvate shunting
contributes to aerobic lactate production by astrocytes.
laconic | pyronic | peredox | FLII12Pglu700μΔ6 | mitoSypHer
Brain tissue is almost exclusively energized by the oxidation ofglucose. However, during neuronal activation, there is a larger
increase in local glucose consumption relative to oxygen con-
sumption (1). As this mismatch occurs in the presence of normal or
augmented oxygen levels, it has been termed aerobic glycolysis,
paralleling the signal detected by functional magnetic resonance
imaging (2). Aerobic glycolysis and its associated lactate surge are
causally linked to diverse functions of the brain in health and dis-
ease (3–10). Two signals are known to trigger aerobic glycolysis in
brain tissue: glutamate and K+, which are released by active neu-
rons and stimulate glycolysis in astrocytes (11, 12).
Neurons produce as much NH+4 as they produce glutamate,
both molecules being stoichiometrically linked in the glutamate-
glutamine cycle (13). Brain tissue NH+4 increases within seconds
of neural activation (14–16) and is quickly released to the
interstitium (17, 18) to be captured by astrocytes through K+
channels and transporters (19). It is well established that chronic
exposure to pathological levels of NH+4 such as those observed
during liver failure has a major impact on brain metabolism, but
it is not known whether this molecule may affect energy me-
tabolism at physiological levels, particularly within the time scale
of synaptic transmission. A previous study showed a reversible
rise in brain tissue lactate and cerebral blood flow within minutes
of an i.v. infusion of NH+4 . In view of this result, NH
+
4 was
speculated to have signaling roles in the brain (20). The aim of
the present work was to investigate this possibility.
Results
Increased Lactate Production and Release by Physiological NH+4 . To
investigate the acute effect of NH+4 on astrocytic metabolism, we
chose 0.2 mM, a concentration within physiological levels in brain
tissue (15, 21, 22). Experiments were carried out in cell cultures, in
acute brain tissue slices and in the somatosensory cortex in vivo.
First, the release of lactate by pure astrocytes in culture during a
1-min exposure to NH+4 was estimated using an enzymatic assay.
Consistent with previous reports (20, 23), a significant increase in
extracellular lactate was observed at 5 mM NH+4 . However, the
enzymatic assay was unable to detect significant lactate release at
0.2 or 0.5 mM NH+4 (Fig. 1A). To improve the sensitivity of de-
tection, lactate was measured within cells using Laconic (24). All
imaging of cultured astrocytes was performed on mixed cultures of
astrocytes and neurons, in which astrocytes are better differenti-
ated in terms of energy metabolism (25). Standard glucose and
lactate concentrations in the superfusate were 1 and 0.5 mM, re-
spectively. Exposure of astrocytes to 0.2 mM NH+4 induced a rapid
and reversible increase in cytosolic lactate, a response that varied
from cell to cell (Fig. 1B). The effect was reproducible (Fig. 1C)
and dose dependent (Fig. 1 D and E). Cultured astrocytes are net
lactate producers. To clarify whether the accumulation of lactate
was due to increased production or impaired release, astrocytes
were exposed to NH+4 in the presence of the monocarboxylate
transporter (MCT) blocker AR-C155858 (26), which in these cells
abrogates lactate transport (24). As shown in Fig. 1F, the increased
rate of lactate accumulation in the presence of the MCT blocker
demonstrates NH+4 stimulated lactate production. Lactate release
was assessed independently by real-time estimation of lactate levels
in the immediate vicinity of astrocytes using a lactate-sniffer HEK
293 cell (27). Seeded on a brain cell culture, lactate sniffers were
observed to lie on top of the astrocytic monolayer (Fig. 1G). As
Significance
Aerobic glycolysis is important for synaptic growth, neuronal
excitability, memory formation, and behavior and is also involved
in neurodegeneration. Here we present evidence, obtained with
novel optical tools, to show that NH+4 contributes to aerobic
glycolysis by specifically inhibiting the mitochondrial consump-
tion of pyruvate in astrocytes. NH+4 , a waste product of excitatory
neurotransmission, is therefore proposed to behave as an in-
tercellular signal in brain tissue.
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shown in Fig. 1 H and I, exposure of the cultures to NH+4 resulted
in a rapid increase in sniffer signal that was variable in amplitude
and reverted to baseline after NH+4 withdrawal. These results show
that astrocytes increase their production and release of lactate
within seconds of exposure to physiological levels of NH+4 .
To verify if the response of astrocytes to NH+4 is detectable in
brain tissue, lactate was measured in protoplasmic astrocytes of
the hippocampus. For this purpose, a recombinant adeno-asso-
ciated virus coding for Laconic under the short gfaABC1D pro-
moter was stereotactically injected into the brain of neonatal mice.
After 4–5 wk, brain slices were prepared, and FRET measure-
ments were made (Fig. 1J). Imaged in tissue slices, the sensor be-
haved as expected, with a decrease in signal on transacceleration of
lactate export with the nonmetabolized MCT substrate mono-
chloroacetate and an increase during exposure to 10 mM lactate
(24). Addition of NH+4 to the slice caused a rapid increase in lactate
in protoplasmic astrocytes, a response that could be detected even
at 0.05 mM NH+4 (Fig. 1K). To approach astrocytic lactate in vivo,
Laconic was expressed in astrocytes of the primary somatosensory
cortex of adult mice and then imaged under anesthesia through a
cranial window using two-photon microscopy (Fig. 2A). An i.v.
bolus injection of NH+4 (2.5 mmol/kg body weight) provoked a quick
rise in astrocytic lactate (Fig. 2B), followed by a rise in extracellular
lactate, as detected by an enzyme-based microelectrode inserted
into the brain tissue (Fig. 2C). Parallel measurements showed no
apparent effects of the NH+4 bolus infusion on blood lactate levels
(Fig. 2D), demonstrating that the changes detected in the brain
were originated locally. Less NH+4 was also capable of increasing
astrocytic lactate, with a lowest effective dose of 0.63 mmol/ kg (Fig.
2E). Considering that a bolus of 2.5 mmol/kg increased brain tissue
NH+4 by 0.7 mM (20), the 0.63 mmol/kg bolus should have increased
brain NH+4 by 0.17 mM. This calculated value, which is close to the
physiological range, is probably an overestimate as it does not take
into account NH+4 clearance by peripheral tissues and by astro-
cytes. Aerobic glycolysis may be triggered by stimulation of
astrocytic glycolysis, such as that observed in response to glu-
tamate or to high K+ (11, 12). To assess glycolysis as a possible
target for NH+4 , astrocytic glucose was measured using the ge-
netically encoded glucose nanosensor FLII12Pglu700μΔ6 (28). As
shown in Fig. S1, exposure to physiological NH+4 levels had no
apparent effect on cytosolic glucose concentration nor on the rate
of glucose consumption measured with a transport block protocol
(29). We conclude that physiological NH+4 does not stimulate
glucose consumption in astrocytes.
Mitochondrial Flux Inhibition by Physiological NH+4 . In lactate pro-
ducers like astrocytes, most NADH is produced in glycolysis.
Measurements with the genetically encoded fluorescent nano-
sensor Peredox (30) showed a decrease in cytosolic NADH in
response to NH+4 (Fig. 3A), a result that is consistent with the
lack of effect of NH+4 on glucose consumption and that also rules
out glycogen as a putative source of lactate. Thus, we focused on
Fig. 1. NH+4 stimulates the production and release of lactate by astrocytes in vitro. (A) Extracellular lactate measurement with an enzymatic kit in pure astrocytic
cultures. Cells were exposed for 1 min to 0.2, 0.5, or 5 mMNH+4 . (B) (Left) Laconic expressed in the cytosol of astrocytes in culture. (Scale bar, 10 μm.) (Right) Effect
of NH+4 on intracellular lactate is shown for 3 representative cells as the change of the mTFP/Venus ratio. (C) An astrocyte was exposed three times to 0.2 mM
NH+4 . (D) Dose dependence of the effect expressed as percentage of cells responding to NH
+
4 with an increase in lactate. Responding cells were distinguished
from nonresponding cells by computing the average of five data points collected just before NH+4 exposure and the average of five data points at 3 min of
exposure. The difference between the two values was considered significant if P < 0.05 (Mann-Whitney u test). The number of monitored cells is given.
(E) Response of a single astrocyte to subsequent exposures to 0.2, 0.5, and 5 mM NH+4 . (F) Astrocytes in glucose alone as energy substrate were first exposed to
the MCT inhibitor AR-C155858 (1 μM) and 2 min later to 0.2 mM NH+4 . Lines represent the rate of lactate accumulation before and during exposure to NH
+
4 . Bars
show averages. (G) (Left) Schematic representation of lactate sniffers above astrocytes. (Right) 3D confocal microscopy reconstruction of HEK 293 lactate sniffers
(blue) and astrocytes loaded with Calcein orange (red). (H) Representative responses of sniffer cells exposed to 0.2 mM NH+4 in the absence and presence of
astrocytes. (I) Bars show average changes in sniffer signal. (J) Protoplasmic astrocytes expressing Laconic in an acute hippocampal slice prepared 4 wk after AAV
injection at P1. (Scale bar, 50 μm.) (K) (Left) Two-point calibration of Laconic with 50 mMmonochloroacetate (MCA) and 10 mM lactate (10L), and response of a
protoplasmic astrocyte to slice exposure to 0.05, 0.1, and 0.2 mMNH+4 . (Right) Dose dependence of the effect expressed as percentage of cells responding to 0.2 mM
NH+4 with an increase in lactate. Responding cells were identified as detailed in D. The number of monitored cells is given. *P < 0.05.
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mitochondrial inhibition as the possible mechanism for the lac-
tate surge. Measurements with the FRET nanosensor Pyronic
(31) supported this hypothesis by showing a rapid increase of
cytosolic pyruvate in response to NH+4 , which could be observed
even at 0.05 mM (Fig. 3B). Next, mitochondrial pyruvate con-
sumption was monitored using a transport block protocol (31).
Briefly, astrocytes were first incubated with pyruvate alone as
energy substrate and then were exposed to a mixture of surface
pyruvate transport blockers, a condition under which the rate of
cytosolic pyruvate depletion represents the rate of mitochondrial
pyruvate consumption. In our culture conditions, the uptake
of pyruvate is partly mediated by a pathway sensitive to AR-
C155858 and by a pathway sensitive to probenecid. As shown in
Fig. 3C, NH+4 markedly decreased mitochondrial pyruvate con-
sumption. To further characterize the dynamics of mitochondrial
inhibition, cells were simultaneously exposed to NH+4 and pyruvate
transport blockers during high-frequency data acquisition. During
the first seconds of exposure, the rate of pyruvate depletion was
similar to that observed in the absence of NH+4 , but then the de-
pletion came to a stop and pyruvate levels began to recover. A
numerical model of pyruvate dynamics could be fitted to the data,
indicating that NH+4 inhibited mitochondrial pyruvate uptake by
93%, with a delay of 30 s between surface transport block and
mitochondrial inhibition (Fig. 3D). The resulting accumulation of
pyruvate in the cytosol pushes the near-equilibrium LDH reaction
toward NADH use and lactate production, thus accounting for the
observed decrease in cytosolic NADH.
Mechanism of Mitochondrial Pyruvate Uptake Inhibition by NH+4 . A
robust cytosolic acidification was obtained with supraphysiological
NH+4 (Fig. 3E), confirming that ammonium enters astrocytes mostly
in the protonated form, a process known to be mediated by K+
channels and transporters (19, 22). Exposure of astrocytes to
physiological NH+4 caused a significant acidification of the mi-
tochondrial matrix, as estimated with MitoSypHer, a genetically-
encoded pH sensor (Fig. 3F). The mitochondrial acidification
suggests that ammonium enters astrocytic mitochondria in the
protonated form. We could not find information about the
mechanisms of mitochondrial NH+4 transport in astrocytes. Pref-
erential NH+4 over NH3 uptake has previously been reported in
liver mitochondria (32). Of note, although NH3 is a gas, it diffu-
sivity through biological membranes can be low, as reported in
kidney cells (33). In contrast, physiological NH+4 did not acidify the
cytosol to a significant extent (Fig. 3E). The absence of cytosolic
acidification by low levels of ammonium is consistent with the
higher pH and lower buffering capacity of the mitochondrial matrix
relative to the cytosol (34), compounded by muffling from the high
levels of cytosolic bicarbonate and carbonic anhydrase present in
astrocytic cytosol (35). The uptake of pyruvate by mitochondria is
mediated by the mitochondrial pyruvate carrier (MPC), which is an
H+-pyruvate cotransporter (36, 37). Therefore, the driving force
for pyruvate uptake depends on the difference between the H+
concentration in the cytosol and that in the more alkaline mito-
chondrial matrix (38). Because the MPC cotransports pyruvate
with an H+, the acidification of mitochondria by physiological NH+4
provides an explanation for the inhibition of pyruvate uptake by
mitochondria. After entering mitochondria, most of the pyruvate is
metabolized via the Krebs cycle. This pathway may be inhibited by
NH3 at α-ketoglutarate dehydrogenase (21), a possible downstream
target for NH+4 after deprotonation. NH
+
4 had no apparent effect
on mitochondrial membrane potential (Fig. 3G). A stable mito-
chondrial potential in the face of matrix acidification has been
previously ascribed to Ca2+ efflux (39), but we could not find a
detectable increase in cytosolic Ca2+ in astrocytes exposed to NH+4
(Fig. S2). An alternative explanation for the constancy of mito-
chondrial potential may be inhibition of ATP synthase mediated by
the H+-sensitive modulator IF1 (40).
Discussion
This article describes a previously unidentified mechanism of
aerobic glycolysis. We found that physiological levels of NH+4
induce a rapid and reversible increase in lactate production and
release by astrocytes, a robust phenomenon observed in cultured
cells, brain tissue slices, and in the somatosensory cortex in vivo.
In contrast to the metabolic roles of glutamate and K+, the
NH+4 -dependent lactate surge was not due to glycolytic stimula-
tion but to pyruvate shunting, explained by acidification of the
mitochondrial matrix. As NH+4 is produced by neurons in an
activity-dependent manner, the present mechanism suggests that
NH+4 diverts lactate from astrocytes to neurons (Fig. 4).
NH+4 as a Marker for Neurotransmission. Astrocytes capture gluta-
mate released during excitatory neurotransmission and send it
back to neurons in the form of glutamine. Within neurons, glu-
tamine is reconverted to glutamate with the stoichiometric pro-
duction of NH+4 (13). The physiological concentration of NH
+
4 in
brain tissue of several species has been estimated at about
0.2 mM (15, 21), with a more recent 0.45 mM measured in mouse
brain interstitium with a double barreled electrode (22). An in-
crease in nervous tissue NH+4 during neural activity has been
reported in several animal models, including frog sciatic nerve
(14), rat brain slices (15), and slices of the bee retina (17). Using
a rapid freezing technique, a transient increase in brain tissue
NH+4 was detected within 5 s of rat paw stimulation (16). It is not
clear whether NH+4 is released together with glutamate during
synaptic vesicle fusion (41) or alternatively through NH+4 -per-
meable ion channels (42). NH+4 is rapidly captured by astrocytes
via several pathways including K+ channels and transporters (19,
22). Nitrogen may also be shuttled from neurons to astrocytes as
Fig. 2. NH+4 increases astrocytic lactate in vivo. (A) Schematic representation
of an in vivo experiment. (Left) Anesthetized mouse previously injected with
AAV9-GFAP-Laconic is positioned in the two-photon microscope setup for
measurement of astrocytic lactate. (Center) Cranial window exposing the
somatosensory cortex. (Scale bar, 1 mm.) (Right) Protoplasmic astrocytes
expressing Laconic in the somatosensory cortex, layer II/III. (Scale bar, 50 μm.)
A bolus of NH+4 (2.5 mmol/kg body weight) was injected i.v. while monitoring
astrocytic lactate with Laconic (B), extracellular lactate with an inserted
biosensor (C), or blood lactate with an enzymatic assay (D). Symbols in
D represent data from four separate experiments. (E) Response of astrocytic
lactate to sequential i.v. injections of increasing doses of NH+4 .
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amino acids, but the extent of this indirect pathway seems to be
less significant than direct transfer as NH+4 (18).
Mechanism of Lactate Production by NH+4 . We observed that NH
+
4
acutely stimulated the production and release of lactate by astro-
cytes without affecting glycolysis. The phenomenon was detected
even at 0.05 mM and coincided with a strong inhibition of pyruvate
uptake by mitochondria. There was a coincidental decrease in cy-
tosolic NADH, consistent with pyruvate to lactate conversion. NH+4
caused an acute acidification of the mitochondrial matrix but no
detectable changes in cytosolic pH. The uptake of pyruvate by mi-
tochondria is mediated by the H+-coupled MPC (36, 37), and
therefore the reduction of the transmitochondrial pH gradient by
NH+4 provides a parsimonious explanation for the reduced uptake
of pyruvate. There is increasing evidence that mitochondrial pH
plays important physiological and pathological roles (43); for ex-
ample, a recent study in astrocytes showed that glutamate inhibited
oxygen consumption, a phenomenon ascribed to cytosolic acidifi-
cation leading to mitochondrial acidification (34).
NH+4 Is a Signal for Aerobic Glycolysis. The control, by neurons, of
astrocytic lactate release appears to involve several mechanisms
acting within different temporal domains. In the short term (sec-
onds), glutamate stimulates the glucose transporter GLUT1 via
Na+ and Ca2+ transients mediated by the Na+-glutamate
cotransporter (44, 45). Acting in parallel, K+ stimulates glycolysis
via the Na+-HCO3
− cotransporter NBCe1 (12, 46) and also
opens a lactate permeable ion channel at the cell surface (27). By
suppressing the uptake of pyruvate by astrocytic mitochondria
within seconds, NH+4 adds an additional strategy for short-term
induction of aerobic glycolysis. Acting on different targets, the
three signals are likely to be synergic. The production of lactate
by astrocytes is also stimulated by neuronal signals in the long
term (minutes). Glutamate activates glycolysis via the Na+-glutamate
cotransporter (11, 12) and K+ stimulates glycogen degradation
via the HCO3
−-sensitive soluble adenylyl cyclase (47). Also within
minutes, nitric oxide has been shown to stimulate astrocytic gly-
colysis through inhibition of cytochrome c oxidase leading to
activation of 5′-AMP–activated protein kinase and PFKFB3 (48).
It seems likely that NH+4 may also have long-term roles in the
control of astrocytic glycolysis and similar mechanisms could be
present in other glial cells. For example, retinal Müller cells have
been shown to increase their production of lactate in response to
NH+4 , but only in the presence of glutamate (49). Cooperativity
might also help to explain the present observation that astrocytes
in brain slices, likely exposed to some glutamate, were found to
be more sensitive to NH+4 than astrocytes in culture. Given the
emerging importance of aerobic glycolysis and lactate for diverse
Fig. 4. Astrocytic lactate release in response to NH+4 . The release of lactate
by astrocytes exposed to NH+4 is explained by the following sequence of
events. (A) NH+4 uptake by astrocytes through K
+ channels and transporters.
(B) NH+4 entry into mitochondria leading to acidification of the mitochondrial
matrix. (C) Inhibition of the H+-coupled MPC. (D) Accumulation of pyruvate
in the cytosol causing lactate accumulation and NADH depletion. (E) In-
creased lactate release.
Fig. 3. Mitochondrial inhibition induced by NH+4 . (A) Cultured astrocytes expressing the NADH/NAD
+ nanosensor Peredox in the nucleus. (Scale bar, 10 μm.)
The graph shows the effect of 0.2 mM NH+4 on the NADH/NAD
+ ratio. (B) Cultured astrocytes expressing the pyruvate nanosensor Pyronic. (Scale bar, 10 μm.)
The graph in the middle shows the effect of 0.2 mM NH+4 on astrocytic pyruvate. (Right) Response of a single astrocyte to subsequent exposures to 0.05, 0.1,
and 0.2 mM NH+4 . Pyruvate in the superfusate (P) was set at 0.025 mM during the stimulations or 0 and 1 mM for calibration purposes. (C) (Upper) Schematic
representation of the method that estimates mitochondrial pyruvate consumption by inhibiting surface pyruvate transport (T) with 100 nM AR-C155858 and
1 mM probenecid (tblock). (Lower) Mitochondrial pyruvate consumption in cells that had been exposed for 3 min to 0.2 mM NH+4 and their controls.
(D) (Upper) Surface pyruvate transport was blocked in the absence and presence of 0.2 mM NH+4 . (Lower) Numerical model represented in the schematic was
fitted (red line) to the pyruvate data (symbols) as described in the SI Text. (Inset) Delay in the onset of the NH+4 effect. (E) Effects of 0.2 and 5.0 mM NH
+
4 on
astrocytic pH, estimated with BCECF. (F) Effect of 0.2 NH+4 on mitochondrial pH, estimated with mitoSypHer. (G) Effects of 0.2 NH
+
4 and 1 μM FCCP on
mitochondrial membrane potential estimated with TMRM. (Scale bars, 10 μm.)
Lerchundi et al. PNAS | September 1, 2015 | vol. 112 | no. 35 | 11093
N
EU
RO
SC
IE
N
CE
local and higher functions of the brain (3–10, 50–55), we hope
that the present findings will stimulate research on the physio-
logical aspects of NH+4 , particularly mitochondrial transport and
neuronal release.
Materials and Methods
Standard reagents and inhibitors were acquired from Sigma or Merck.
AR-C155858 was purchased from Haoyuan Chemexpress. The sensors
FLII12Pglu700μΔ6, Peredox, Laconic, Pyronic, and MitoSypHer are available
from Addgene (www.addgene.org). Ad Laconic, Ad Pyronic, and Ad
FLII12Pglu700μΔ6 (serotype 5) were custom made by Vector Biolabs. The
adeno-associated virus (AAV9) expressing Laconic under the control of the
short gfaABC1D promoter was generated at the École Polytechnique Fédérale
de Lausanne. Design, production, and titration of the AAV9 vector for trans-
gene expression in astrocytes have been described previously (56). Fluo-4 AM,
2,7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) AM, tetramethyl
rhodamine methyl ester (TMRM), and Calcein AM were from Invitrogen. All
NH+4 application were in the form of NH4Cl. At pH 7.4 and 23 °C, 99% is in
the ionized form (NH+4 ), and 1% is in the neutral form (NH3).
Animals and Brain Cell Culture. All animal procedures for the in vitro exper-
iments were approved by the Institutional Animal Care and Use Committee of
the Centro de Estudios Científicos. Animals used for primary cultures and
brain slices were mixed F1 male mice (C57BL/6J × CBA/J), kept in an animal
room under SPF conditions at a room temperature of 20 ± 2 °C, in a 12/12-h
light/dark cycle and with free access to water and food. Procedures for
in vivo experiments were approved by the local veterinary authorities,
conforming to the guidelines of the Swiss Animal Protection Law, Veterinary
Office, Canton Zurich (Act of Animal Protection 16 December 2005 and
Animal Protection Ordinance 23 April 2008). WT mice (C57BL/6J; Harlan
Laboratories) 10 wk of age and with a body weight of 20 g were housed in
single cages, with free access to water and food. Mixed brain cell primary
cultures were prepared as detailed previously (46). To measure lactate re-
lease with an enzymatic method, pure astrocytic cultures were obtained by
subculturing mixed cultures at day 14. After another 7 d in 24-well plates,
cultures were exposed to experimental conditions in a 95% air/5% CO2-
gassed culture saline buffer (CSF) composed of (mM) 112 NaCl, 3 KCl, 1.25
CaCl2, 1.25 MgCl2, 2 glucose, 10 Hepes, and 24 NaHCO3, pH 7.4, at room
temperature. Extracellular lactate was measured using a fluorometric assay
kit according to the manufacturer´s instructions (BioVision). For FRET
sensor expression, cultures were exposed to 5 × 106 PFU of Ad Laconic, Ad
Pyronic, or Ad FLII12Pglu700μΔ6 and studied after 48 h (culture day 8–10).
For plasmid expression of Peredox and mitoSypHer, cells were transfected
using Lipofectamine 2000 or 3000 (Gibco) and studied after 48 h (culture
day 8–10). The cytosolic and nuclear versions of Peredox responded simi-
larly to NH+4 , as expected from unrestricted movement of NADH and NAD
+
through the nuclear pore (30). However, the expression of nuclear Peredox
was much stronger. Thus, we chose to illustrate NADH dynamics using
nuclear Peredox. To generate lactate sniffers (27), HEK293 cells were first
transfected with Laconic. After 24 h, the cells were detached with trypsin
for 2 min, washed three times, and seeded on top of a mixed brain cell
culture. The coculture was maintained with Neurobasal medium for 12–24 h
until imaging.
Hippocampal Slices. Neonatal mice (postnatal days 1–2) were removed from
the mother and anesthetized by hypothermia for 8 min. Animals were po-
sitioned on a stereotactic stage (57) and injected with 1 μL AAV9-GFAP-
Laconic directly through the skull using a Fusion 100 Syringe Pump (Chemyx).
After injection, animals were positioned on a temperate bed until recovery
and returned to the mother. Four weeks after AAV injection, animals were
killed by cervical dislocation, and 200-μm-thick coronal brain sections were
prepared as described (58).
In Vivo Two-Photon Microscopy of Somatosensory Cortex. The protocol for
in vivo determination of astrocytic lactate with Laconic has been detailed
elsewhere (27). In brief, animals were anesthetized with an intraperitoneally
injected mixture of fentanyl (0.05 mg/kg body weight; Sintenyl, Sintetica),
midazolam (5 mg/kg body weight; Dormicum, Roche), and medetomidine
(0.5 mg/kg body weight; Domitor, Orion Pharma) and again after 50 min
with midazolam only (5 mg/kg body weight). The head was fixed in a ste-
reotactic apparatus, and the eyes were kept wet with an ointment (vitamin
A eye cream; Bausch & Lomb). A 4 × 4-mm craniotomy was drilled using a
dental drill, and 75 nL AAV9-GFAP-Laconic (titer 3.1 × 1012 vg/mL) was in-
jected into the primary somatosensory cortex. A square coverslip (3 × 3 mm;
UQG Optics Ltd.) was lightly pressed on the exposed brain and fixed with
dental cement to the skull. A bonding agent (Gluma Comfort Bond; Heraeus
Kulzer) was applied to the cleaned skull and was polymerized with a
handheld blue light source (600 mW/cm2; Demetron LC, Kerr Corporation).
The open skin was treated with an antibiotic ointment (Cicatrex; Janssen-
Cilag AG) and closed with acrylic glue (Histoacryl; B. Braun). After surgery,
the animals were kept warm and provided with analgesics (Novaminsulfon,
50%; Sintetica), and the antibiotic enrofloxacin was added to the drinking
water (200 mg/L drinking water; Baytril, Bayer). For in vivo lactate mea-
surements, mice were imaged with a custom-built two-photon laser-scan-
ning microscope using a tunable pulsed (Mai Tai eHP DS system; Spectra-
Physics) at a wavelength of 870 nm. The animals were head fixed and kept
under anesthesia, as described above. Body temperature was kept constant
with a feedback-controlled heating pad (37 °C; Harvard Apparatus). Extra-
cellular lactate measurements were performed with the commercially
available recording system from Pinnacle Technology. Mice were fixed in a
stereotactic frame under anesthesia (isoflurane 1.5%; Abbott), the skull was
opened with a dental drill, and a guide cannula (Part 7032; Pinnacle Tech-
nology) was implanted into the primary somatosensory cortex (A/P +1.41,
M/L −2.8, D/V −1.0) and fixed with dental cement to an anchor screw (Part
8209; Pinnacle Technology). After a recovery period of 2 wk, the precali-
brated lactate sensor was inserted into the guide cannula. A tail vein
catheter was created for saline, lactate, and pyruvate infusions. Recording
was started 1 h after signal stabilization. For blood lactate level measure-
ments, the femoral artery was exposed and cannulated with fine bore
polyethylene tubing (0.28 mm ID, 0.61 mm OD, Portex; Smiths Medical).
Blood drops were removed from the cannula, and every fourth drop was
used for an enzymatic lactate assay (Lactate Pro-2; Arkray). After each
blood sample analysis, the tubing was rinsed with heparinized (50 IU/mL)
0.9% saline solution.
In Vitro Fluorescence Imaging. Detailed protocols for the use of the fluores-
cent sensors are available (59–62). Cells and slices were imaged with an
upright Olympus FV1000 confocal microscope and a 440-nm solid-state laser.
Alternatively, cells were imaged with Olympus IX70 or BX51 microscopes
equipped with Cairn Research monochromators and Optosplits and either a
Hamamatsu Orca or Rollera camera. Cells were superfused at 1 mL/min
(chamber volume, 0.3 mL) at room temperature (22–24 °C): Cultures were
superfused with a 95% air/5% CO2-gassed CSF (1 mM glucose and 0.5 mM
NaLactate), and tissue slices with a 95% O2/5% CO2-gassed solution com-
posed of (mM) 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1.25 CaCl2, 1.25 MgCl2, 10
glucose, and 26 NaHCO3, at pH 7.4. Cell cultures were imaged approximately
30 min after Neurobasal removal; Typical time between animal killing and
slice imaging was 2 h. Masked ratio images were generated from back-
ground-subtracted images using ImageJ software. Fluo4 was ester loaded at
4 μM for 15 min. BCECF was ester loaded at 0.1 μM for 3–4 min. Calcein
orange was ester loaded at 1 μM for 30 min. BCECF and mitoSypHer were
calibrated by exposing the cultures to different pH in the presence of
10 μg/mL nigericin and 20 μg/mL gramicidin in an intracellular buffer. The per-
meabilization procedure shifted the mitoSypHer signal, and therefore
baseline mitochondrial pH was assumed to be 7.6 (34). For mitochondrial
membrane potential imaging the cultures were loaded with the fluorescent
dye TMRM for 30 min at 37 °C.
Data Presentation and Statistical Analysis: Line traces without errors represent
individual cells. Traces with error bars correspond to mean ± SEM of eight or
more cells (n ≥ 3 experiments). Differences between two groups were
evaluated with the Student t test or the Mann-Whitney u test, and differ-
ences between more groups were evaluated with the Kruskal–Wallis one-
way ANOVA on ranks followed by Dunn´s test. P < 0.05 was considered
significant. The computer simulation of pyruvate dynamics is described in
SI Text.
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SI Text
Mathematical Modeling. Cytosolic pyruvate dynamics in the absence
of glucose weremodeled using theminimal differential equation dPyr/
dt = T-M*Pyr, where dPyr/dt is determined by the balance between
surface pyruvate transport (T) and mitochondrial pyruvate metabo-
lism, a function of cytosolic pyruvate concentration (Pyr) with the
constant of proportionality M. As the steady-state cytosolic pyruvate
concentration was measured at 0.2 mM (see Fig. 3D), the model
could be simplified by assuming M = T*5. The differential equation
was solved by numerical simulation using the Rosenbrock iteration
procedure with the computer software Berkeley Madonna
where tblock is the degree of pharmacological inhibition of surface
pyruvate transport; squarepulse(onx, durx) is a function of value
0 except during the interval of duration durx starting at onx, at
which its value is 1; NH+4 block is the degree of inhibition of mi-
tochondrial pyruvate uptake by NH+4 ; and squarepulse (on2 + D,
dur3) is a function of value 0 except during the interval of duration
dur3 starting at on2 + D, at which its value is 1. D represents the
delay between the onset of the surface transport block and the onset
of the mitochondrial block.
dPyr

dt=T p ½1− tblock p squarepulseðon1, dur1Þ p ½1− tblock p squarepulseðon2, dur2Þ−Μ p pyr p

1−ΝΗ+4 block p squarepulseðon2þD, dur3Þ

Fig. S1. Physiological NH+4 does not stimulate glucose consumption by astrocytes. (A) Cultured astrocytes expressing the glucose nanosensor FLII
12Pglu700μΔ6.
(Scale bar, 10 μm.) The graph shows the effect of 0.2 mM NH+4 on cytosolic glucose. (B) (Left) Response of a single astrocyte to subsequent exposures to 0.2, 0.5,
1, and 5 mM NH+4 . Glucose was removed (0G) at the end of the experiment for calibration purposes. (Right) Average effects expressed as percentage of cells
responding to NH+4 with a decrease in cytosolic glucose. (C) Schematic representation of the method that estimates glucose consumption by inhibiting the
glucose transporter GLUT1 with cytochalasin B. (D) (Left) Measurement of glucose consumption in a single astrocyte with 20 μM cytochalasin B before and
during exposure to 0.2 mM NH+4 . (Right) Glucose consumption rates estimated in several similar experiments. *P < 0.05.
Lerchundi et al. www.pnas.org/cgi/content/short/1508259112 1 of 2
Fig. S2. No apparent effect of NH+4 on cytosolic [Ca
2+] in astrocytes. Mixed brain cell cultures loaded with Fluo4 were sequentially exposed to 0.2 mM NH+4 , to
50 μM ATP, and again to 0.2 mM NH+4 . (Upper) Normalized data from a single astrocyte. (Lower) Data from 33 astrocytes in three separate experiments,
showing average values of five data points recorded just before addition (control), after 30 and 60 s of NH+4 exposure and at the peak of the ATP response.
*P < 0.05.
Lerchundi et al. www.pnas.org/cgi/content/short/1508259112 2 of 2
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General Discussion 
 
Brain energy metabolism has been suggested to be highly compartmentalized on a cellular level in a 
way that astrocytes play a pivotal role in satisfying the neuronal energy need (for reviews see e.g. 
11,59,148). Glucose is the main fuel for the brain. However, according to the ANLS hypothesis, glucose is 
preferentially taken up by astrocytes, which then provide hungry neurons with energy rich substrates 
such as lactate. Even though sugar transport is a passive protein-mediated bidirectional process, some 
studies reported putatively disproportionate cellular glucose uptake in various neural tissue 
preparations using radiolabeled or fluorescent glucose derivatives: Vega et al. described 
disproportionally high 78% of glucose uptake into Schwann cells (glial cells of peripheral nerves)149. 
Likewise, in the central nervous system compartmentation of glucose uptake was shown with about 
50% uptake in astrocytes141, despite of neurons being the main energy consumers in the brain, as about 
90% of ATP usage has been allocated to neurons48,150. In agreement, only few years ago, the first in 
vivo measurements tried to translate in vitro findings into the in vivo situation using the fluorescent 
dye 6-NBDG and two-photon microscopy, also pointing to primary glucose uptake in astrocytes151. 
However, this type of experiments is limited by the use of highly artificial surrogate markers for the 
measurement of processes related to the turnover of endogenous glucose. Another 
compartmentalized metabolite according to the ANLS hypothesis is lactate. The only method currently 
available that can measure cellular lactate levels is the fluorescent lactate sensor Laconic, which has 
only been used in artificial preparations like cell cultures so far152. However, lactate has been shown to 
be able to sustain neuronal activity during glucose deprivation153,154 and to be used as brain energy 
substrates in patients with non-penetrating traumatic brain injuries155.  
During this project, the implementation of multiple FRET biosensors for in vivo brain imaging in mice 
on a cellular level using TPLSM was demonstrated. The new possibilities and also limitations of the 
individual sensors were presented to an academic field, which heads towards higher spatial and 
temporal resolutions and more physiological experimental settings. 
We were able to demonstrate transitions of cellular metabolite concentrations during different 
interventions such as the application of glucose, lactate, pyruvate or ammonium concentration 
gradients from the blood to the brain tissue. However, FRET sensors hold the potential for absolute 
concentration measurements, but the necessary calibration of the sensors remains a major challenge: 
We suggested a calibration protocol for the glucose sensor FLIPΔ6 and the lactate sensor Laconic, but 
we have limited tools to control the pyruvate sensor Pyronic. Nevertheless, we could demonstrate the 
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rate-limiting transport of glucose along the blood brain barrier and cellular membranes and the cellular 
compartmentation of resting lactate concentrations.  
 
Implications, limitations and future directions 
The projects presented in this doctoral thesis resulted in a novel FRET based methodology that allowed 
monitoring astrocytic and neuronal glucose, lactate and pyruvate concentrations in a semi-
quantitative manner. So far, it was only possible to use this methodology in cell cultures and slices but 
not in the living mammal. Additionally, this methodology holds the potential to measure metabolite 
concentrations more quantitatively using the substrate binding kinetics of the sensor e.g. in 
experiments with two sensors with the same substrate specificity but different substrate affinities. 
Absolute metabolite levels in different cell-types can only be compared with FRET sensors, if the 
sensors could be calibrated in each ROI of each experiment individually. I presented above an in vivo 
calibration protocol for Laconic revealing higher baseline lactate levels in astrocytes. However, the 
reliable calibration of the glucose sensor FLIPΔ6 is more complicated, as we only achieved partial 
glucose deprivation and filling in astrocytes and neurons in our experiments. So far, I lack a solid 
strategy to calibrate Pyronic, why it could only be used qualitatively as a control construct for Laconic. 
However, the use of intravenous oxamate, which accumulates in astrocytes and neurons and is sensed 
by Pyronic might allow a one-point calibration of Pyronic via saturation.  
Interestingly, astrocytic and neuronal glucose levels were much more dependent on blood glucose 
levels than on neuronal activity. This can be explained by nicely balanced cellular glucose uptake and 
consumption rates under physiological conditions. The pronounced glucose transients in astrocytes 
compared to neurons can be explained by a higher capacity of astrocytes to increase glucose uptake 
and consumption. Therefore, astrocytes are more exposed to larger glucose transients in conditions of 
increased neuronal energy needs or extreme blood glucose levels, placing the astrocytic compartment 
between the vascular and the neuronal compartment, as it has been suggested by the ANLS18. By 
partially outsourcing glycolysis to astrocytes and relying on their lactate production for energy supply, 
neurons can might prefer the pentose phosphate pathway for glucose to protect themselves from 
excessive metabolic stress during depolarization156. 
An activation of transport across the predominant astrocytic glucose transporter GLUT1 upon 
stimulation has been shown in vitro150, while neuronal glucose transport during activation has been 
shown to be rather inhibited157,158. Furthermore, a limited importance of neuronal glucose transport 
can also be suggested by the absence of a phenotype when GLUT3 was decreased by half159. The 
hypothesis of neurons being incompetent to upregulate glycolytic activity is supported by findings of 
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constant degradation of 6‐phosphofructo‐2‐kinase/ fructose‐2, 6‐bisphosphatase‐3160. This enzyme 
generates fructose‐2,6‐bisphosphate which regulates the activity of 6‐phosphofructo‐1‐kinase, a rate 
determining enzyme in glycolysis which is necessary to increase the activity of the glycolytic pathway. 
It has been suggested that neurons may profit from a shuttling of glucose towards the pentose 
phosphate pathway at the expense of its use in the glycolytic pathway for regeneration of reduced 
glutathione to decrease oxidative stress156. Correspondingly, the silencing of enzymes of the glycolytic 
cascade in astrocytes but not in neurons did affect survival and behavior of drosophila flies161.  
However, systemically supplied lactate has been shown to be able to prevent neuronal damage during 
hypoglycemia154,162. Accordingly, astrocytes possess unique cytoarchitectural and phenotypic features 
that predestine them to fulfill such a metabolic gatekeeper function163,164.  
Our results may also help for a better understanding of deoxyglucose-based approaches often used in 
humans such as positron emission tomography165. However, the preferential site of glucose 
metabolism cannot be resolved by radiotracer-based methods with their limited spatial resolution. 
Other available techniques to determine processes related to cerebral energy metabolism in situ such 
as NMR spectroscopy, functional MRI or the just recently introduced MR technique based on glucose 
chemical exchange saturation transfer lack cellular resolution and may profit from deeper single cell-
based insights for proper interpretation166,167.  
In the present work, we observed higher glucose transients upon changes of blood glucose levels in 
astrocytes compared to neurons. The pronounced glucose uptake in astrocytes despite lower global 
energy requirements compared to neurons supports the shuttle concept of energy-rich substrates 
such as lactate between astrocytes and neurons. Consistently, we observed a higher resting level of 
lactate in astrocytes under resting conditions168. This lactate in astrocytes could constitute an energy 
reservoir for neurons169. Indeed we observed during increased neuronal activity an early dip of 
astrocytic lactate followed by a large increase of neuronal and astrocytic lactate, which could represent 
an increase of lactate transport followed by increased lactate production47. This increase of astrocytic 
lactate production could be induced by ammonium released by activated neurons, a mechanism that 
we could mimic by injecting ammonium chloride in living mice94. 
The brain is in a very specific metabolic state under the anaesthetic protocol used. Brain metabolism 
is known to depend on systemic metabolic states in the blood compartment and the neuronal activity 
state. Therefore, brain energy metabolism needs to be investigated at variable physiological and 
pathological vegetative, cognitive and systemic metabolic states. For example, we found a profound 
increase of cellular lactate concentrations under Isoflurane but not triple anaesthesia, which are 
probably different from awake metabolic states. We found only minor glucose and lactate changes in 
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the somatosensory cortex upon physiological peripheral stimulation. The reason might be that 
physiological stimuli induce neuronal activity only in a small fraction of the neurons in the 
corresponding layer 2/3 cortex. To measure fast and localized changes in metabolite levels, the 
simultaneous measurement of neuronal calcium using TPLSM to correlate electrical with metabolic 
cellular events is necessary and in theory possible. Alternatively, silicate windows with slits were 
evaluated to repetitively apply intracortical microelectrode stimulation, which induced large Laconic, 
Pyronic and FLIPΔ6 transients. Specifically, microstimulation revealed the lactate surge as a potential 
vasodilator during increased neuronal activation and possibly also isoflurane anaesthesia. If lactate 
mediates the vasodilation and brain edema induced by isoflurane, this could be prevented by lactate 
dehydrogenase blockage. To investigate the effect of the main astrocytic connexins 30 and 43 on 
cellular lactate levels and transients as it was part of the initial thesis proposal, an inducible knockout 
would be favorable and is now under evaluation. Cortical glucose consumption rates are altered under 
multiple pathological conditions such as brain tumors (Warburg effect), ischemia or Alzheimer’s 
disease so that information about altered cellular metabolite levels could help for a better 
understanding of these pathologies. Other cell types such as oligodendrocytes have impaired energy 
metabolism in pathologies such as neurodegeneration170 and could be specifically targeted using the 
FRET sensors presented in this work. To read out metabolic rates rather than concentrations using 
FRET sensors, specific and fast interventions such as with the ITM are necessary. However, it was not 
possible to apply the necessary blockers intra-cortically in sufficient speed and dosages in the living 
mouse during TPLSM.  
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Figure i-9: Simplified ANLS model. A simplified model of brain energy metabolism with the 
compartments blood, extracellular space (ECF), astrocytes and neurons is given to illustrate the 
dependency of intercellular lactate flux from cellular lactate levels. In this thesis the levels of the key 
substrates glucose, lactate and pyruvate where investigated in astrocytes and neurons and glucose 
and lactate was also assessed in the blood and ECF compartments. 
 
In summary, the possibilities and limitation of in vivo metabolic FRET imaging using TPLSM on cellular 
level are demonstrated in this work. Specifically, differences of glucose and lactate transients between 
the astrocytic and neuronal compartment provided in vivo evidence for the existence of an ANLS 
(Figure i-9). The methodology holds the potential of increased spatial, temporal and qualitative read-
outs, which might further enlighten the role of metabolic signaling of varying brain states, brain 
regions, cellular compartments and pathologies.   
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